Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001467	s-afluust	u/l (u/l)	2205	2705	0.00%
3001467	luusto-is	u/l (—)	864	979	100.00%	Distribution not available
3001467	afosluusto	u/l (u/l)	518	581	0.00%
3001467	s-afluust	— (—)	337	361	100.00%	Distribution not available
3001467	afosluusto	— (—)	138	145	100.00%	Distribution not available
3001467	s-afosluu	u/l (u/l)	97	105	0.00%
3001467	s-luust	u/l (—)	91	100	100.00%	Distribution not available
3001467	afosluu	u/l (u/l)	76	90	0.00%
3001467	alkalinenfosfataasi(afos)	u/l (u/l)	18	18	0.00%
3001467	alkalinenfosfataasi(afos)	— (—)	6	6	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases

1316

2051

3.55

314.53

1.2

57.01

72.01

u/l

4.17

1201

1832

Autoimmune diseases excluding thyroid diseases, strict definition

1273

1965

3.60

310.34

1.2

56.77

72.73

u/l

4.34

1164

1754

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1305

2737

3.34

309.26

1.2

69.12

62.02

u/l

0.99

1198

2438

Care involving dialysis

330

202

18.05

307.65

1.4

1.2

73.22

68.47

u/l

0.13

314

178

Dialysis, with operation codes

437

367

12.87

307.65

1.4

1.2

73.19

73.46

u/l

0.01

414

327

Nephropathy related operations

412

380

11.71

307.65

1.4

1.2

75.07

71.05

u/l

0.19

392

342

ILD medications: immunosuppressive drugs

1044

2124

4.67

307.65

1.2

71.23

62.63

u/l

1.08

954

1889

All chronic kidney diseases

907

1612

4.71

307.65

1.2

62.60

65.11

u/l

0.30

846

1422

Renal failure

864

1463

5.38

307.65

1.2

63.28

68.01

u/l

0.57

807

1282

Chronic kidney disease

688

995

7.06

307.65

1.3

1.2

63.91

68.97

u/l

0.58

645

873

Diseases of liver

775

1325

6.08

307.65

1.2

52.36

65.51

u/l

5.28

708

1176

Renal tubulo-interstitial diseases

1199

2635

3.44

304.95

1.2

64.96

63.98

u/l

0.10

1110

2328

Transplanted organ and tissue status

297

268

11.86

284.55

1.4

1.1

105.72

69.20

u/l

1.61

281

244

Anaemias

377

218

11.57

283.54

1.3

1.2

72.18

63.35

u/l

0.62

353

199

Other diseases of liver

440

667

6.92

277.60

1.2

54.47

63.55

u/l

1.69

402

596

All kidney diseases

1244

2710

3.18

272.86

1.2

66.23

65.24

u/l

0.10

1146

2409

First line medication for Crohn's disease

1298

2193

3.24

270.73

1.3

1.1

70.32

63.56

u/l

0.81

1188

1944

ILD medications

1336

2327

3.15

267.43

1.3

1.2

70.43

63.83

u/l

0.80

1218

2077

Autoimmune diseases related-to ILD

1106

3027

3.17

257.45

1.2

55.99

67.64

u/l

4.38

1013

2708

Extracorporeal dialysis

232

166

15.40

257.43

1.4

1.2

74.34

60.98

u/l

1.25

222

154

ILD medications: prednisolone, methylprednisolone, prednisone

1280

2316

3.13

256.35

1.3

1.1

70.53

63.54

u/l

0.84

1172

2067

Preparatory care for dialysis

204

117

19.81

254.94

1.4

1.2

72.16

51.54

u/l

3.04

193

110

Other bacterial diseases

1205

2643

3.11

253.25

1.3

1.2

72.91

61.98

u/l

1.65

1119

2333

Bacterial infection, other or unspecified

780

1813

3.81

240.20

1.3

1.2

75.42

60.56

u/l

2.30

738

1586

Bacterial infection, other or unspecified

821

1922

3.68

239.10

1.3

1.2

75.03

60.55

u/l

2.37

775

1683

L04AD Calcineurin inhibitors

299

349

9.10

237.40

1.4

1.1

106.86

61.53

u/l

2.34

279

323

Fibrosis and cirrhosis of liver

249

241

11.16

227.96

1.3

1.1

46.31

64.48

u/l

3.03

231

221

Glomerular disorders in diseases classified elsewhere

293

358

8.64

223.99

1.3

1.2

62.30

63.84

u/l

0.11

284

321

Inflammatory bowel disease treatment related agents

1308

2601

2.84

223.70

1.2

66.34

64.97

u/l

0.12

1189

2330

Other bacterial diseases

1199

2657

2.90

220.44

1.3

1.2

73.30

62.54

u/l

1.58

1113

2354

Glomerular diseases

373

621

6.25

214.38

1.3

1.2

65.35

70.92

u/l

0.41

360

552

L04AA Selective immunosuppressants

437

846

5.35

213.48

1.3

1.1

83.46

61.87

u/l

1.52

405

754

Any gastric operation

775

994

3.95

206.98

1.2

1.1

67.43

66.48

u/l

0.07

719

835

GASTRO-related operations

775

994

3.95

206.98

1.2

1.1

67.43

66.48

u/l

0.07

719

835

Kidney transplant status

188

140

14.68

203.70

1.4

1.2

86.43

75.60

u/l

0.24

176

130

Heart failure, not strict

954

2106

3.12

202.82

1.2

65.92

65.00

u/l

0.07

879

1855

Autoimmune diseases

1173

2073

2.91

201.91

1.2

59.69

72.19

u/l

2.91

1056

1853

Abnormal findings on examination of blood, without diagnosis

660

1666

3.71

199.19

1.2

57.95

65.39

u/l

1.26

609

1470

Bacterial Sepsis

661

1549

3.72

196.08

1.3

1.2

70.87

63.97

u/l

0.50

614

1367

Second line medication for Crohn's disease

782

2455

3.24

195.92

1.2

67.39

63.20

u/l

0.31

713

2186

ILD medications: azathioprine

286

396

7.48

195.70

1.3

1.1

85.11

59.77

u/l

0.94

262

352

Secondary hypertension

210

194

11.28

194.74

1.3

1.1

70.11

61.34

u/l

0.99

198

172

Septicaemia

589

1427

3.94

194.59

1.3

1.1

72.88

62.15

u/l

0.70

548

1249

IBD patients in KELA-register

393

762

5.30

191.32

1.3

1.2

57.39

63.68

u/l

0.86

351

684

Implicit bacterial Sepsis

592

1375

3.90

189.49

1.3

1.2

71.44

63.95

u/l

0.50

547

1202

Primary biliary cholangitis (PBC)

132

27.35

187.09

1.3

1.0

46.11

53.39

u/l

0.72

121

Other septicaemia

536

1294

4.07

186.50

1.3

1.1

73.34

59.98

u/l

0.92

499

1124

Inflammatory bowel disease, strict (require KELA)

393

794

5.09

182.52

1.3

1.2

57.39

63.15

u/l

0.78

351

715

Explicit Sepsis

600

1545

3.69

181.07

1.3

1.2

72.53

63.47

u/l

0.57

559

1365

Azathioprine

286

431

6.87

181.06

1.3

1.1

85.11

61.67

u/l

0.84

262

385

Acute renal failure

360

682

5.44

180.02

1.2

65.01

68.38

u/l

0.32

337

594

Fever of other and unknown origin

692

1869

3.34

177.77

1.3

1.2

67.06

66.35

u/l

0.06

651

1660

Used for control exclusion in common control thyroid runs

1052

1866

2.88

177.56

1.2

60.02

73.52

u/l

2.82

951

1668

L04AX Other immunosuppressants

745

2411

3.14

177.38

1.2

68.15

63.12

u/l

0.36

679

2147

Implicit bacterial Sepsis

617

1506

3.61

175.69

1.3

1.2

70.81

64.06

u/l

0.46

571

1325

Dialysis

149

101

16.23

170.29

1.4

1.2

79.80

81.14

u/l

0.02

142

5-aminosalicylic acid

344

660

5.35

169.42

1.3

1.2

55.34

63.25

u/l

1.65

307

584

Oral corticosteroids

1124

2572

2.62

168.63

1.2

61.12

64.75

u/l

0.59

1025

2303

Polyarthropathies

840

1834

3.03

168.43

1.2

56.80

68.79

u/l

3.55

764

1648

Noninfective enteritis and colitis

619

1866

3.37

165.53

1.3

1.2

56.93

67.21

u/l

2.54

564

1658

Inflammatory bowel disease

471

1202

4.00

162.25

1.3

1.2

56.99

63.29

u/l

1.17

426

1073

Implicit Sepsis

876

2384

2.81

159.97

1.2

66.32

62.87

u/l

0.30

801

2105

Aplastic and other anaemias

619

1778

3.30

157.43

1.3

1.2

68.13

64.10

u/l

0.26

568

1573

Persons encountering health services for specific procedures and health care

1132

2758

2.48

153.48

1.3

1.2

74.48

61.70

u/l

2.17

1048

2451

Insulin, fast-acting

484

1330

3.71

149.67

1.3

1.2

59.86

67.04

u/l

1.54

446

1176

Dental caries

379

835

4.46

148.93

1.3

1.2

81.73

62.85

u/l

1.37

352

740

Reimbursement for rheumatic diseases

724

2546

2.87

147.56

1.2

53.97

64.09

u/l

3.93

662

2257

Disorders of parathyroid gland

370

849

4.44

144.59

1.3

1.2

73.80

58.68

u/l

3.46

340

748

Nonalcoholic fatty liver disease

228

345

6.94

144.41

1.2

57.57

58.74

u/l

0.09

202

315

Ulcer of lower limb, not elsewhere classified

269

482

5.79

143.30

1.3

1.1

51.86

73.89

u/l

2.67

252

428

Abnormal serum enzyme levels

416

1030

4.03

143.25

1.3

1.2

56.20

68.93

u/l

1.81

383

909

Tramadol

868

1974

2.73

142.54

1.2

59.95

57.17

u/l

0.60

776

1770

Disorders resulting from impaired renal tubular function

132

100

14.52

141.75

1.4

1.2

73.30

76.31

u/l

0.04

123

Mucosal proctocolitis

232

364

6.59

141.39

1.3

1.1

51.84

64.67

u/l

1.89

205

329

Budesonide

256

443

5.97

141.34

1.4

1.1

52.64

59.76

u/l

1.31

232

394

Insulin, fast-acting or short human

486

1395

3.55

140.74

1.3

1.2

59.86

69.11

u/l

1.59

448

1234

Unspecified kidney failure

200

271

7.68

139.79

1.2

69.32

67.88

u/l

0.06

182

240

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1022

2725

2.47

139.65

1.3

1.2

67.73

64.10

u/l

0.46

932

2436

Diabetic nephropathy, excluding more controls

295

455

5.55

139.49

1.3

1.2

62.70

59.62

u/l

0.27

283

402

Osteopathies and chondropathies

697

2302

2.86

138.90

1.3

1.2

68.83

61.34

u/l

1.48

635

2047

Ulcerative colitis

366

873

4.29

138.34

1.3

1.2

57.54

64.30

u/l

0.94

328

779

Caries of dentine

338

733

4.59

138.14

1.3

1.2

71.27

63.29

u/l

0.61

314

649

Cholangitis (primary sclerosing, PSC)

161

171

9.97

137.48

1.3

1.2

56.09

67.09

u/l

0.83

148

154

Implicit Sepsis

893

2562

2.58

137.44

1.2

66.01

63.63

u/l

0.19

814

2266

Other dialysis

123

15.40

135.87

1.4

1.2

66.81

84.63

u/l

0.27

118

Any reimbursement code in KELA

471

570

4.18

135.01

1.2

1.1

68.28

60.79

u/l

0.55

428

510

Insulin, intermediate and long-acting

643

2174

2.92

133.92

1.2

57.97

65.13

u/l

1.82

591

1936

Other anaemias

557

1695

3.18

133.78

1.2

67.34

64.54

u/l

0.16

512

1500

Other and unspecified anaemias

550

1683

3.17

131.53

1.2

67.49

64.61

u/l

0.16

505

1491

Hyperparathyroidism

330

753

4.47

130.15

1.3

1.2

74.16

58.36

u/l

3.53

302

664

Metabolic disorders

1005

2555

2.42

130.13

1.2

64.73

63.30

u/l

0.18

910

2289

Diabetic nephropathy

297

624

4.88

129.78

1.3

1.1

62.54

60.18

u/l

0.23

285

551

Disorders of gallbladder, biliary tract and pancreas

1049

2829

2.36

129.49

1.2

55.96

63.91

u/l

2.84

951

2533

Insulin, combination of fast acting with intermediate-acting or long-acting

699

2353

2.75

128.93

1.3

1.2

64.21

64.95

u/l

0.05

644

2099

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

287

599

4.92

128.46

1.3

1.2

56.13

64.02

u/l

1.18

256

542

Disorders of other endocrine glands

560

1822

3.07

128.19

1.2

71.91

63.84

u/l

1.24

512

1623

Ulcerative colitis (strict definition, require KELA)

273

550

5.10

127.42

1.3

1.2

56.38

63.51

u/l

0.96

243

498

Insulin medication

699

2162

2.75

126.90

1.3

1.2

64.21

66.11

u/l

0.13

644

1933

Type 1 diabetes

341

824

4.21

126.30

1.3

1.2

60.36

67.61

u/l

1.20

317

733

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

266

531

5.15

125.51

1.3

1.2

56.62

63.98

u/l

0.96

237

481

Type 1 diabetes, wide definition, subgroup 1

290

635

4.66

122.07

1.3

1.2

60.38

67.79

u/l

1.02

272

570

Condition for Implicit Sepsis (Organ dysfunction codes)

891

2609

2.43

121.12

1.2

66.28

64.06

u/l

0.18

815

2312

Pneumonias (Asthma/COPD co-morbidities)

1012

2987

2.29

119.30

1.3

1.2

72.18

63.07

u/l

1.03

930

2665

Heart failure,strict

580

1374

3.02

118.49

1.2

58.57

66.89

u/l

0.97

526

1195

Crohn disease

217

382

5.86

117.70

1.3

1.2

60.59

66.00

u/l

0.38

196

346

All pneumoniae

1014

2999

2.28

117.60

1.3

1.2

72.44

63.04

u/l

1.08

931

2677

Influenza and pneumonia

1042

2951

2.26

117.51

1.3

1.2

71.35

63.14

u/l

0.92

958

2633

Condition for Implicit Sepsis (Organ dysfunction codes)

903

2643

2.38

116.02

1.2

66.42

64.54

u/l

0.15

824

2349

Pneumonia, organism unspecified

926

2807

2.33

114.66

1.3

1.2

73.25

63.52

u/l

1.00

847

2496

915

2378

2.35

110.88

1.3

1.2

64.09

63.61

u/l

0.05

840

2126

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

915

2378

2.35

110.88

1.3

1.2

64.09

63.61

u/l

0.05

840

2126

Type 1 diabetes, wide definition

292

695

4.28

110.48

1.3

1.2

60.15

67.04

u/l

0.98

274

624

Malignant neoplasm of breast, HER2-negative

561

1269

2.94

106.85

1.2

59.88

56.51

u/l

1.10

520

1122

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

972

3009

2.22

106.77

1.3

1.2

72.79

63.20

u/l

1.05

894

2682

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

240

509

4.86

105.64

1.2

53.36

65.89

u/l

2.13

223

452

Heart failure and antihypertensive medication

327

516

4.22

105.52

1.2

61.97

65.76

u/l

0.25

300

450

Certain infectious and parasitic diseases

905

1941

2.35

104.17

1.2

67.42

63.14

u/l

0.44

813

1724

Malignant neoplasm of breast

560

1281

2.90

103.93

1.2

59.68

56.30

u/l

1.11

519

1134

General symptoms and signs

987

2208

2.26

103.51

1.2

62.22

65.61

u/l

0.48

890

1973

Nutritional anaemias

579

2106

2.69

103.35

1.2

64.22

61.47

u/l

0.29

537

1873

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1066

2709

2.15

102.65

1.2

64.15

64.85

u/l

0.08

990

2407

Implicit viral Sepsis

356

1028

3.52

102.39

1.2

58.48

62.65

u/l

0.66

332

898

Malignant neoplasm of breast, HER2-negative, including Hilmo

564

1296

2.86

102.25

1.2

59.35

56.23

u/l

1.00

524

1147

Malignant neoplasm of breast, including Hilmo

564

1296

2.86

102.23

1.2

59.35

56.23

u/l

1.00

524

1147

Malignant neoplasm

832

2108

2.36

100.80

1.2

73.17

58.17

u/l

3.49

769

1868

Acute tubulo-interstitial nephritis

634

2162

2.56

100.39

1.2

65.36

64.04

u/l

0.10

580

1905

Diseases of oesophagus, stomach and duodenum

1021

2863

2.15

100.25

1.2

59.19

64.51

u/l

0.96

924

2572

Ulcerative colitis, NAS

213

428

5.11

99.81

1.2

56.98

66.75

u/l

1.06

189

383

Malignant neoplasm of breast, HER-positive

451

1151

3.11

99.39

1.2

1.1

60.28

57.11

u/l

0.86

423

1014

Malignant neoplasm of breast, ER-positive, including Hilmo

453

1160

3.07

97.16

1.2

1.1

60.36

57.06

u/l

0.92

425

1022

Hypertensive diseases (excluding secondary)

526

1051

2.94

97.00

1.2

69.96

64.68

u/l

0.30

480

949

Examination and observation for other reasons

599

1290

2.71

95.80

1.2

60.96

68.85

u/l

1.02

558

1140

Complications of surgical and medical care, not elsewhere classified

971

3157

2.12

95.62

1.2

59.70

64.51

u/l

1.18

889

2827

Sub-endpoint used in defining T1D endpoints

349

1021

3.41

95.47

1.3

1.2

60.05

69.72

u/l

1.21

325

912

Other disorders of fluid, electrolyte and acid-base balance

388

1169

3.22

95.32

1.2

64.59

62.49

u/l

0.19

358

1029

Iron deficiency anaemia

498

1792

2.78

95.31

1.2

65.50

61.14

u/l

0.45

462

1596

Oedema, not elsewhere classified

384

1204

3.20

94.37

1.2

53.20

63.38

u/l

3.35

347

1067

Malignant neoplasm, wide definition for exclusion

831

2147

2.29

94.25

1.2

72.07

58.64

u/l

2.97

768

1903

Heart failure, strict

617

1714

2.57

93.86

1.2

58.10

66.17

u/l

1.11

555

1516

Ulcerative colitis (strict definition, all Crohn cases excluded)

209

442

4.85

92.20

1.3

1.2

55.13

65.29

u/l

1.31

187

397

Other Crohn's disease

133

183

7.56

91.81

1.3

1.1

61.39

63.04

u/l

0.06

117

169

Gout, FINNGEN

329

977

3.42

90.24

1.2

59.95

66.25

u/l

0.85

298

862

Osteoporosis

367

1085

3.23

90.00

1.2

1.1

65.40

58.30

u/l

1.49

331

966

Malaise and fatigue

529

1613

2.67

89.84

1.2

56.02

65.21

u/l

1.95

474

1435

Hypertension, essential

736

1774

2.37

89.25

1.2

61.27

65.03

u/l

0.50

670

1595

Implicit viral Sepsis

260

667

3.98

89.19

1.3

1.2

61.00

64.67

u/l

0.40

246

587

Viral Sepsis

260

667

3.98

89.19

1.3

1.2

61.00

64.67

u/l

0.40

246

587

Solid cancers, helper endpoint

797

2090

2.27

88.98

1.2

72.03

57.85

u/l

3.01

734

1850

Other disorders of kidney and ureter

209

456

4.73

88.97

1.3

1.2

68.49

68.80

u/l

0.01

194

408

Hypertension

744

1805

2.35

88.29

1.2

69.22

67.77

u/l

0.09

678

1626

Gout

329

857

3.44

88.14

1.2

59.95

68.18

u/l

0.77

298

754

Any event in cancer register

843

2266

2.21

88.14

1.2

72.45

58.46

u/l

3.10

772

2019

Other and unspecified iron deficiency

397

1341

3.01

88.07

1.2

68.08

62.61

u/l

0.46

367

1189

Erysipelas

683

2238

2.35

88.02

1.2

60.49

60.83

u/l

0.02

615

1962

Hypertensive diseases

743

1805

2.34

87.95

1.2

69.20

67.77

u/l

0.08

677

1626

All-cause Heart Failure

600

1700

2.52

87.88

1.2

58.80

66.38

u/l

0.98

538

1504

Insulin, fast-acting (human)

191

391

4.99

87.51

1.3

1.1

62.07

64.69

u/l

0.18

177

348

Oxycodone

427

1350

2.90

87.02

1.3

1.2

98.66

56.04

u/l

4.15

405

1199

Finngen Rheumatological endpoints

871

2297

2.17

86.84

1.2

61.71

66.49

u/l

0.82

789

2071

Hernia of abdominal wall, postoperative

189

386

4.98

86.67

1.3

1.1

62.99

64.84

u/l

0.08

175

320

Persons encountering health services in other circumstances, wide

1063

2719

2.03

86.37

1.2

63.53

64.82

u/l

0.15

979

2417

Erysipelas

545

1933

2.52

84.38

1.2

62.60

59.89

u/l

0.15

495

1690

Infections, IBD-co-morbidities

190

263

5.25

81.57

1.3

1.2

62.51

76.19

u/l

0.57

173

238

Other disorders of skin and subcutaneous tissue

711

2910

2.19

80.19

1.2

57.42

63.22

u/l

1.45

649

2599

L02BG Aromatase inhibitors

409

1482

2.81

79.89

1.2

60.58

59.37

u/l

0.23

384

1306

Opioids

854

2090

2.14

79.82

1.2

64.61

58.68

u/l

1.20

762

1879

Other heart diseases

449

1054

2.81

79.57

1.2

77.78

66.76

u/l

0.52

421

948

Cirrhosis of liver, NAS

116

163

7.49

78.86

1.3

1.2

46.70

57.50

u/l

0.97

111

150

Diseases of arteries, arterioles and capillaries (FINNGEN)

285

551

3.64

77.37

1.3

1.2

65.63

63.25

u/l

0.18

262

488

Medicines for HER+ breast cancer

458

1706

2.59

75.40

1.2

60.23

58.51

u/l

0.41

429

1513

Crohn's disease NAS

117

174

6.98

75.28

1.3

1.1

61.31

64.18

u/l

0.11

104

164

Chronic hepatitis, not elsewhere classified

100

9.58

74.46

1.2

1.1

48.75

52.87

u/l

0.41

Pain in limb

746

2358

2.13

74.14

1.2

60.87

67.03

u/l

1.14

673

2111

Other diseases of intestines

919

2637

1.99

73.66

1.2

63.30

67.95

u/l

0.45

822

2375

Cholelithiasis, broad definition with cholecystitis

805

2673

2.04

71.58

1.2

54.05

62.22

u/l

2.81

732

2387

Diarrhoea and gastroenteritis of presumed infectious origin

652

2749

2.15

70.77

1.2

73.64

63.81

u/l

0.73

592

2461

Codeine

788

2062

2.09

70.68

1.2

58.16

58.25

u/l

0.01

704

1852

Cardiovascular diseases (excluding rheumatic etc)

521

1215

2.48

70.47

1.2

78.05

67.09

u/l

0.61

485

1098

Disorders of mineral metabolism

138

258

5.52

70.40

1.3

1.2

71.71

60.90

u/l

0.68

127

228

Intestinal infectious diseases

854

3318

1.97

70.23

1.2

68.37

62.89

u/l

0.48

777

2978

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

651

2734

2.15

70.22

1.2

59.61

61.99

u/l

0.34

596

2421

Amputation

153

314

5.01

70.11

1.3

1.2

54.71

63.97

u/l

0.88

147

280

Exposure to unspecified factor

897

3353

1.94

69.96

1.2

63.61

65.49

u/l

0.25

780

3048

Liquid cancers, helper endpoint

379

1217

2.75

69.62

1.2

64.17

59.98

u/l

0.33

350

1069

Complications of medical and surgical care

711

3196

2.06

69.16

1.2

57.77

62.50

u/l

1.24

656

2853

Diabetes, varying definitions

915

2775

1.95

68.97

1.2

65.14

64.85

u/l

0.02

832

2493

Gout, strict definition

218

593

3.75

68.96

1.2

59.53

68.52

u/l

0.89

200

517

Endocrine, nutritional and metabolic diseases

628

1401

2.28

68.38

1.2

66.26

70.93

u/l

0.43

573

1256

Gout, idiopatic and unspecified

276

878

3.20

68.23

1.2

60.89

66.19

u/l

0.57

252

772

Other inflammatory liver diseases

116

190

6.33

68.03

1.2

1.1

50.02

59.79

u/l

0.84

107

174

Gastrointestinal diseases

445

830

2.70

67.95

1.2

67.59

70.88

u/l

0.18

412

730

Gout, unspecified

236

685

3.51

67.68

1.2

61.76

67.35

u/l

0.50

216

596

Crohn's disease of large intestine

101

145

7.26

67.23

1.3

1.2

70.17

65.09

u/l

0.18

134

Complications of procedures, not elsewhere classified

747

3087

2.02

67.19

1.2

58.92

63.78

u/l

1.07

681

2760

Intestinal infectious diseases

1015

3129

1.86

66.99

1.2

61.47

64.42

u/l

0.40

924

2807

Diabetes mellitus

912

2782

1.93

66.98

1.2

64.63

65.04

u/l

0.03

829

2500

Bleeding

770

2755

2.00

65.81

1.2

60.93

63.72

u/l

0.48

697

2454

Abnormal results of function studies

137

273

5.17

65.07

1.2

1.1

51.69

64.48

u/l

1.47

123

249

Diseases of the digestive system

462

1951

2.38

64.95

1.3

1.2

65.22

65.20

u/l

0.00

423

1739

Other heart diseases, wide

796

2467

1.99

64.29

1.2

70.01

66.83

u/l

0.21

722

2222

Other noninfective gastroenteritis and colitis

279

924

3.06

64.27

1.2

57.09

71.03

u/l

1.86

256

814

Cholelithiasis

761

2648

2.00

63.98

1.2

53.76

62.33

u/l

2.93

692

2366

Biological medication for rheuma

215

612

3.58

63.57

1.2

51.32

62.35

u/l

2.46

198

555

Peripheral artery operations in Hilmo

168

403

4.26

63.30

1.3

1.2

55.03

66.54

u/l

1.29

160

358

Hypothyroidism (congenital or acquired)

184

226

4.64

63.05

1.2

60.68

60.74

u/l

0.00

167

205

Diabetic maculopathy, excluding more controls

145

311

4.77

63.03

1.3

1.2

65.39

60.23

u/l

0.47

130

278

Heart failure and bmi 25plus

362

903

2.74

61.99

1.2

58.43

60.24

u/l

0.12

328

803

Other soft tissue disorders, not elsewhere classified

800

2405

1.96

61.85

1.2

61.10

68.75

u/l

1.40

726

2155

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

849

2685

1.92

61.83

1.2

64.87

64.54

u/l

0.02

767

2408

Crohn disease (strict definition, require KELA)

110

188

6.05

61.80

1.2

61.00

60.68

u/l

0.01

176

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

114

202

5.83

61.67

1.2

60.95

60.87

u/l

0.00

101

188

Diseases of the skin and subcutaneous tissue

839

2166

1.95

61.64

1.2

61.74

67.67

u/l

0.97

755

1933

Diseases of arteries, arterioles and capillaries

628

2226

2.10

61.58

1.2

59.19

62.31

u/l

0.49

578

1974

Glomerulonephritis

142

306

4.77

61.47

1.3

1.2

73.47

78.81

u/l

0.18

133

275

Crohn disease (strict definition, require KELA, min 2 HDR)

109

186

6.06

61.34

1.2

60.87

u/l

0.00

174

Crohn's disease of small intestine

110

190

5.97

61.09

1.4

1.2

55.99

61.09

u/l

0.43

100

177

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

587

2782

2.10

60.85

1.2

58.80

63.11

u/l

0.89

540

2477

Hypothyroidism, levothyroxine purchases

180

225

4.56

60.60

1.2

60.28

60.87

u/l

0.04

163

204

Hypothyroidism and >3 levothyroxin purchases

180

225

4.56

60.60

1.2

60.28

60.87

u/l

0.04

163

204

Hyperkalaemia

146

6.81

60.52

1.3

1.2

75.57

59.92

u/l

0.61

127

Other arthritis (FG)

319

1177

2.74

60.31

1.2

52.58

64.53

u/l

4.04

295

1044

Acute peritonitis

109

190

5.94

60.04

1.2

70.03

63.21

u/l

0.42

100

172

Other retinal disorders

610

2294

2.09

59.61

1.3

1.2

59.36

64.04

u/l

0.86

543

2062

Nausea and vomiting

290

1002

2.87

59.45

1.3

1.2

76.50

69.23

u/l

0.24

268

884

Ascites

119

230

5.34

58.58

1.3

1.2

54.12

65.93

u/l

1.07

111

211

Other diseases of biliary tract

130

274

4.88

57.84

1.3

1.2

57.93

62.67

u/l

0.37

124

244

Other and unspecified polyneuropathies, also in other diseases

223

692

3.28

57.60

1.2

52.10

68.12

u/l

3.84

203

615

Other diseases of blood and blood-forming organs, wide

263

899

2.98

57.53

1.2

81.53

63.85

u/l

0.93

244

794

Diabetes, insulin treatment (Kela reimbursement)

891

2944

1.84

57.29

1.2

63.96

64.16

u/l

0.01

806

2645

Pain in joint

507

1452

2.24

56.57

1.2

56.12

68.82

u/l

3.53

453

1305

Tumor necrosis factor alpha inhibitors

188

532

3.60

56.15

1.2

52.11

62.26

u/l

1.81

173

488

Type 2 diabetes, wide definition

726

2404

1.95

56.09

1.2

59.68

64.54

u/l

0.93

658

2144

Disorders of choroid and retina

739

2761

1.92

55.74

1.2

57.97

63.33

u/l

1.34

652

2480

Sulfasalazine

290

1065

2.76

55.38

1.2

55.82

62.04

u/l

1.38

265

944

Gastro-oesophageal reflux disease

610

2632

2.01

55.25

1.2

58.46

64.12

u/l

0.64

553

2357

Diabetes medication

888

2916

1.82

54.67

1.2

64.28

64.78

u/l

0.04

802

2623

Disorders of thyroid, IBD co-morbidities

170

298

4.05

54.17

1.2

73.82

67.59

u/l

0.25

152

269

Peripheral artery disease

424

1466

2.33

54.12

1.2

56.25

64.25

u/l

1.31

394

1292

Medical observation and evaluation for suspected diseases and conditions

548

1295

2.18

53.76

1.2

65.47

68.80

u/l

0.28

501

1145

Ulcerative ileocolitis

114

7.32

53.68

1.1

1.2

52.26

55.48

u/l

0.22

104

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

118

245

4.96

53.50

1.3

1.2

57.51

63.04

u/l

0.33

110

219

Heart failure and coronary heart disease

419

1274

2.36

53.49

1.2

54.62

63.52

u/l

1.57

380

1124

Infections of the skin and subcutaneous tissue

512

2436

2.10

53.09

1.3

1.2

65.20

67.93

u/l

0.25

465

2187

Diabetic retinopathy, strict definition

228

655

3.14

52.95

1.3

1.2

59.73

59.93

u/l

0.02

212

591

Certain infectious and parasitic diseases

588

1406

2.11

52.90

1.2

62.80

64.96

u/l

0.20

531

1250

Disorders of lipoprotein metabolism and other lipidaemias

713

2316

1.92

52.53

1.2

58.38

63.56

u/l

1.00

642

2067

Type 2 diabetes

838

2702

1.82

52.03

1.2

58.62

63.04

u/l

0.96

762

2426

Other specified/unspecified arthritis

284

1067

2.70

51.94

1.2

52.35

66.68

u/l

4.52

264

948

Disorders of calcium metabolism

102

192

5.49

51.76

1.3

1.2

72.36

62.12

u/l

0.47

170

Polyneuropathies and other disorders of the peripheral nervous system

239

822

2.96

51.75

1.2

52.47

68.26

u/l

4.15

218

725

Rheumatoid arthritis

339

1234

2.49

51.67

1.2

54.30

64.92

u/l

3.46

309

1100

Abnormalities of breathing

731

2247

1.90

51.63

1.2

55.94

68.65

u/l

4.20

655

2019

Neoplasms

541

1349

2.14

51.28

1.2

67.07

65.21

u/l

0.14

489

1210

Systemic connective tissue disorders

367

1570

2.37

50.96

1.2

57.09

61.13

u/l

0.43

337

1398

Asthma, unspecified (mode), excluding more controls

432

1444

2.25

50.82

1.2

54.52

66.69

u/l

2.98

388

1278

Codeine or tramadol medication

940

2951

1.75

50.50

1.2

58.74

62.63

u/l

0.93

832

2660

Chronic pancreatitis

149

388

3.92

50.35

1.2

53.40

65.41

u/l

1.96

132

346

Spondyloarthritis

181

540

3.40

49.76

1.2

55.28

62.77

u/l

0.90

171

478

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

535

2677

2.01

49.63

1.2

58.54

61.72

u/l

0.64

490

2387

Noninfectious colitis NAS

158

434

3.71

49.39

1.2

1.1

57.62

66.76

u/l

0.62

146

387

COPD/asthma related infections

849

2379

1.80

48.55

1.3

1.2

62.10

63.59

u/l

0.18

771

2127

COPD/asthma/ILD related infections

849

2379

1.80

48.55

1.3

1.2

62.10

63.59

u/l

0.18

771

2127

Diarrhoea and gastroenteritis of presumed infectious origin

841

3156

1.77

48.43

1.2

67.19

63.23

u/l

0.31

766

2829

Ulcerative rectosigmoiditis

105

217

4.95

47.82

1.4

1.1

53.17

62.71

u/l

0.98

199

Constipation

777

3015

1.79

47.66

1.2

63.53

62.52

u/l

0.11

696

2705

Dermatitis and eczema

916

3316

1.72

47.62

1.2

59.19

66.51

u/l

1.97

831

2981

Hypothyroidism, drug reimbursement

116

166

4.99

47.36

1.2

55.82

58.68

u/l

0.24

105

150

Hypothyroidism, strict autoimmune

532

1726

2.04

47.29

1.2

56.92

65.54

u/l

2.32

475

1532

Diseases of peritoneum

138

357

3.96

47.16

1.2

68.07

61.92

u/l

0.53

123

321

Other medical care

409

1686

2.20

47.13

1.3

1.2

88.64

61.76

u/l

3.42

387

1487

Explicit bacterial Sepsis

121

285

4.33

46.81

1.3

1.2

66.63

62.98

u/l

0.15

115

252

Diabetic retinopathy, excluding more controls

289

600

2.74

46.80

1.3

1.2

59.48

59.78

u/l

0.03

260

533

Dyspnoea

768

3201

1.78

46.76

1.2

55.29

65.03

u/l

4.12

694

2875

Asthma, excluding more controls

578

1510

2.01

46.47

1.2

56.63

67.73

u/l

2.47

524

1339

Hypertensive heart and/or renal disease

250

671

2.81

46.39

1.2

54.72

71.71

u/l

2.00

230

597

Continuous positive airway pressure

189

496

3.25

46.38

1.2

53.93

70.01

u/l

2.10

179

438

Seropositive rheumatoid arthritis

263

1008

2.63

45.92

1.2

55.07

63.68

u/l

2.09

241

892

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

119

182

4.71

45.45

1.2

61.55

61.06

u/l

0.02

109

165

Certain disorders involving the immune mechanism

214

745

2.92

45.42

1.2

72.26

65.19

u/l

0.17

198

668

Primary hyperparathyroidism

158

461

3.52

45.31

1.2

68.83

56.98

u/l

1.35

145

420

Covid-19 confirmed case

341

1494

2.31

44.82

1.3

1.2

69.31

63.56

u/l

0.32

319

1320

Oesophageal varices

131

6.21

44.80

1.2

65.43

57.51

u/l

0.39

120

Atherosclerosis, excluding cerebral and coronary sclerosis

381

1358

2.24

44.79

1.2

58.97

64.82

u/l

0.71

353

1198

Cardiovascular diseases

419

1014

2.23

44.46

1.2

83.04

69.77

u/l

0.59

388

915

Streptococcal septicaemia

101

215

4.80

44.41

1.4

1.1

66.05

64.48

u/l

0.05

189

Adjustment and management of implanted device

183

591

3.14

44.29

1.2

1.1

56.49

67.56

u/l

0.71

167

518

Pain, not elsewhere classified

260

1014

2.59

44.15

1.3

1.2

57.99

64.12

u/l

0.71

240

904

Other ulcerative colitis

157

5.57

44.05

1.3

1.2

69.42

61.30

u/l

0.26

144

Other diseases of the digestive system

305

1283

2.40

44.04

1.2

64.28

65.35

u/l

0.08

279

1132

Other specific joint derangements/joint disorders

573

1926

1.93

43.79

1.2

56.86

70.84

u/l

3.56

512

1737

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

365

1007

2.31

43.47

1.3

1.2

60.62

62.82

u/l

0.23

332

906

Fracture of femur

270

975

2.54

43.08

1.3

1.1

70.97

60.68

u/l

1.28

240

868

GI-bleeding

300

1272

2.38

42.56

1.2

64.70

65.27

u/l

0.04

273

1126

Low back pain

627

2458

1.84

42.30

1.2

56.11

64.26

u/l

3.24

570

2207

Symptoms and signs involving the digestive system and abdomen

782

2233

1.76

42.19

1.2

65.70

67.98

u/l

0.20

702

1993

Asthma, unspecified (mode)

435

1585

2.08

42.11

1.2

54.36

65.57

u/l

2.81

391

1399

Vitreous haemorrhage

129

345

3.83

42.09

1.4

1.2

60.00

64.80

u/l

0.36

117

310

Cutaneous abscess, furuncle and carbuncle

247

967

2.58

41.69

1.2

65.85

61.77

u/l

0.31

227

867

Other diseases of pleura

403

1688

2.11

41.68

1.2

71.95

65.42

u/l

0.28

367

1491

Cardiac arrhythmias

472

1520

2.03

41.44

1.2

70.27

67.71

u/l

0.11

428

1366

Non-ischemic cardiomyopathy

299

1012

2.41

41.37

1.2

64.81

65.92

u/l

0.05

268

898

Follow-up examination after treatment for conditions other than malignant neoplasms

379

1146

2.20

41.20

1.2

58.07

63.31

u/l

0.97

344

1008

Asthma

597

1661

1.89

40.89

1.2

56.40

66.62

u/l

2.37

541

1469

Fall on same level

896

2948

1.67

40.45

1.3

1.2

68.27

64.92

u/l

0.29

788

2674

Persons encountering health services in other circumstances

331

1493

2.22

40.04

1.2

61.61

65.50

u/l

0.45

300

1315

Hypo-osmolality and hyponatraemia

186

640

2.93

39.91

1.2

57.72

60.58

u/l

0.29

174

564

Other nutritional deficiencies

551

2820

1.85

39.71

1.2

61.61

62.24

u/l

0.07

500

2523

Dermatitis

529

2841

1.87

39.55

1.2

60.38

63.08

u/l

0.38

468

2536

Other and unspecified dermatitis

453

2322

1.97

39.52

1.2

60.98

61.89

u/l

0.10

407

2065

Enterocolitis due to Clostridium difficile

127

351

3.69

39.48

1.3

1.1

61.84

61.74

u/l

0.01

121

312

Fungal Sepsis

113

6.24

39.44

1.4

1.2

66.25

56.47

u/l

0.52

104

Congenital malformations of the urinary system

166

5.15

39.40

1.3

1.2

84.07

74.18

u/l

0.22

156

Abdominal and pelvic pain

768

2233

1.74

39.36

1.2

62.68

67.98

u/l

0.58

687

1993

Other systemic involvement of connective tissue (FG)

249

993

2.50

39.26

1.2

59.18

62.94

u/l

0.26

224

876

Pure hypercholesterolaemia

608

2187

1.83

39.12

1.2

58.29

63.76

u/l

0.94

548

1944

Other bacterial intestinal infections

184

641

2.91

39.04

1.2

61.73

63.87

u/l

0.16

168

571

Asthma (only as main-diagnosis), excluding more controls

512

1510

1.95

39.00

1.2

57.88

67.73

u/l

1.90

471

1339

Disorders of lens

598

2045

1.84

38.88

1.3

1.2

62.86

63.17

u/l

0.03

555

1813

Atrial fibrillation and flutter

279

740

2.47

38.80

1.2

63.37

66.09

u/l

0.18

260

659

Other diseases of pancreas

104

253

4.21

38.74

1.2

58.96

63.09

u/l

0.29

232

Antihypertensive medication - note that there are other indications

408

1023

2.12

38.38

1.2

75.42

70.92

u/l

0.18

378

915

Congenital malformations of the urinary system

178

4.91

38.24

1.3

1.2

83.23

74.41

u/l

0.20

166

Rheumatoid arthritis, including avohilmo

368

1777

2.09

38.04

1.2

54.93

62.63

u/l

2.55

333

1580

Alcoholic liver disease

113

298

3.87

37.63

1.2

1.1

58.50

69.70

u/l

0.91

103

265

Adalimumab

111

289

3.92

37.63

1.1

53.71

68.10

u/l

1.49

103

264

Asthma (mode)

579

1679

1.86

37.56

1.2

56.59

66.60

u/l

2.32

525

1485

Implicit fungal Sepsis

197

4.64

37.44

1.3

1.1

73.78

55.97

u/l

1.67

179

Benzodiazepine use

807

3372

1.66

37.32

1.2

58.49

64.05

u/l

1.18

724

3037

Osteoporosis with pathological fracture (FG)

102

252

4.16

37.28

1.2

1.1

61.77

56.55

u/l

0.54

223

Other diseases of intestine

157

516

3.09

37.01

1.3

1.2

82.49

65.59

u/l

0.31

137

456

Cholecystectomy

614

3026

1.76

36.99

1.2

55.62

60.50

u/l

1.25

555

2708

Arthropathies in other diseases classified elsewhere

6.52

36.96

1.4

1.1

54.29

58.69

u/l

0.27

Other functional intestinal disorders

390

1802

2.02

36.51

1.2

62.62

66.41

u/l

0.44

357

1610

Pleural effusion

162

547

3.01

36.44

1.1

1.2

60.90

63.97

u/l

0.17

145

485

Iron deficiency anaemia secondary to blood loss (chronic)

168

579

2.95

36.41

1.2

57.40

64.52

u/l

0.70

157

523

Pain in throat and chest

645

2209

1.76

36.38

1.2

57.81

66.40

u/l

2.37

581

1983

Cystic kidney disease

109

6.14

36.32

1.3

1.2

73.07

55.52

u/l

0.88

102

Cystic kidney disease

113

6.00

36.09

1.3

1.2

72.64

55.03

u/l

0.91

106

Parasetamol

533

1437

1.89

35.96

1.2

63.48

68.29

u/l

0.48

475

1307

Hypokalaemia

130

390

3.39

35.67

1.2

62.42

61.02

u/l

0.08

117

345

Chronic gastritis

259

1115

2.35

35.64

1.2

58.74

65.79

u/l

1.16

227

989

Other diseases of urinary system

791

2688

1.66

35.62

1.2

65.04

63.13

u/l

0.17

703

2435

Haemorrhage from respiratory passages

304

1251

2.21

35.62

1.2

64.87

65.34

u/l

0.01

273

1107

Other necrotizing vasculopathies

226

4.27

35.62

1.2

45.59

58.54

u/l

2.60

207

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

242

464

2.63

35.54

1.2

1.1

62.72

68.63

u/l

0.44

222

406

Valvular heart disease excluding rheumatic fever

387

1378

2.04

35.44

1.2

74.00

67.38

u/l

0.23

351

1222

All influenza

218

874

2.52

35.07

1.3

1.2

61.24

63.83

u/l

0.24

206

773

Diabetic retinopathy

346

1012

2.16

35.02

1.3

1.2

59.49

58.66

u/l

0.10

314

911

Non-rheumatic valve diseases

384

1370

2.04

34.92

1.2

64.96

66.97

u/l

0.10

348

1216

Injuries to the hip and thigh

410

1910

1.96

34.88

1.3

1.2

67.16

60.59

u/l

1.09

364

1703

Other disorders of urethra and urinary system

584

2393

1.77

34.85

1.2

62.58

63.26

u/l

0.07

525

2168

Paralytic ileus and intestinal obstruction

241

1015

2.40

34.81

1.3

1.2

58.17

64.35

u/l

1.01

223

900

Polycystic kidney disease

6.87

34.75

1.3

1.2

64.86

56.57

u/l

0.45

Hyperlipidaemia, other/unspecified

328

1441

2.11

34.47

1.2

56.46

64.15

u/l

1.36

290

1277

Cellulitis

206

813

2.56

34.33

1.3

1.2

60.46

64.30

u/l

0.24

191

726

Chronic tubulo-interstitial nephritis

108

5.93

34.27

1.3

1.2

64.51

55.31

u/l

0.47

101

Crohn disease (strict definition, all UC cases excluded)

152

5.01

34.11

1.2

52.88

58.51

u/l

0.50

143

Other necrotizing vasculopathies (FG)

156

4.93

34.03

1.3

1.1

43.90

64.99

u/l

3.20

139

Nephrotic syndrome

6.48

33.64

1.3

1.2

83.54

91.43

u/l

0.09

Persons encountering health services for specific procedures, not carried out

210

4.27

33.59

1.3

1.1

58.83

57.07

u/l

0.11

190

Bacterial intestinal infections, IBD co-morbidities

187

712

2.66

33.57

1.2

61.20

64.82

u/l

0.31

171

629

Viral pneumonia

127

390

3.31

33.56

1.3

1.2

66.14

64.12

u/l

0.12

116

352

Unspecified privation

116

337

3.50

33.51

1.2

54.79

65.45

u/l

1.36

100

306

Collagenous colitis

108

300

3.68

33.43

1.2

49.69

59.81

u/l

1.36

271

Cerebrovascular diseases (FINNGEN)

258

781

2.36

33.37

1.2

60.48

64.06

u/l

0.40

237

698

Excluding asthma or asthma-COPD overlap

594

1679

1.78

33.30

1.2

62.94

66.60

u/l

0.41

542

1487

Coagulation defects, purpura and other haemorrhagic conditions

191

740

2.62

33.11

1.3

1.2

64.37

68.69

u/l

0.20

181

667

Complications of internal orthopaedic prosthetic devices, implants and grafts

221

918

2.44

33.06

1.3

1.2

56.76

64.97

u/l

1.19

199

798

Lower back pain or/and sciatica

820

3359

1.60

32.98

1.2

55.33

63.97

u/l

4.08

739

3020

Other bacterial intestinal infections

212

867

2.47

32.78

1.2

61.73

63.51

u/l

0.15

191

771

Depression medications

156

243

3.24

32.64

1.2

65.13

63.00

u/l

0.11

137

221

Asthma (only as main-diagnosis)

520

1661

1.82

32.50

1.2

57.69

66.62

u/l

1.76

477

1469

Atrial fibrillation and flutter with reimbursement

228

586

2.50

32.48

1.2

60.50

64.53

u/l

0.26

203

519

Agranulocytosis

128

405

3.22

32.30

1.2

82.44

62.58

u/l

1.22

121

367

Obesity and other hyperalimentation

506

2756

1.78

32.29

1.2

57.91

62.97

u/l

1.19

461

2469

Other pulmonary diagnosis

589

1679

1.77

32.13

1.2

63.04

66.60

u/l

0.40

536

1487

Obesity

503

2747

1.78

31.98

1.2

57.96

63.00

u/l

1.18

459

2460

Presence of other functional implants

485

1856

1.82

31.68

1.2

57.19

64.12

u/l

1.45

441

1640

Peripheral arterial reconstruction

161

587

2.78

31.49

1.2

54.42

66.96

u/l

1.75

147

518

COPD differential diagnosis

586

1679

1.76

31.44

1.2

62.88

66.60

u/l

0.42

535

1485

ILD differential diagnosis

586

1679

1.76

31.43

1.2

62.88

66.60

u/l

0.42

535

1485

Symptoms and signs involving the circulatory and respiratory systems

738

2255

1.65

31.37

1.2

58.69

68.67

u/l

2.53

671

2026

Other CVD (FINNGEN)

112

246

3.58

31.25

1.3

1.2

62.09

61.50

u/l

0.03

221

Benign neoplasm of colon, rectum, anus and anal canal

531

2660

1.74

31.10

1.2

58.67

62.37

u/l

0.55

479

2365

Primary_lymphoid and hematopoietic malignant neoplasms

224

963

2.35

31.04

1.2

70.43

69.84

u/l

0.02

210

850

Psoriatic and enteropathic arthropathies

119

369

3.28

31.01

1.2

59.98

64.15

u/l

0.28

108

330

Chronic apical periodontitis

853

3115

1.57

30.44

1.2

62.00

62.92

u/l

0.13

763

2808

Ulcerative proctitis

163

4.58

30.41

1.4

1.2

52.73

66.42

u/l

1.26

151

129

425

3.08

30.35

1.3

1.2

74.97

57.68

u/l

1.05

113

382

Depression

737

3124

1.61

30.27

1.2

57.32

64.21

u/l

2.68

656

2810

Other gastritis (incl. Duodenitis)

206

863

2.41

30.26

1.2

59.05

67.23

u/l

0.79

185

758

Codes for special purposes

420

2291

1.84

30.25

1.3

1.2

66.41

61.95

u/l

0.30

394

2040

Other antidepressants

784

2516

1.60

30.16

1.2

60.67

64.72

u/l

0.63

696

2280

Arthropathies

653

1977

1.68

30.10

1.2

61.93

72.35

u/l

1.76

598

1786

Other systemic involvement of connective tissue

257

1186

2.19

30.04

1.2

59.28

59.73

u/l

0.03

232

1051

Artificial opening status

153

4.70

29.99

1.3

1.2

119.11

78.88

u/l

0.33

142

Fracture of lumbar spine and pelvis

205

861

2.40

29.84

1.2

63.61

61.77

u/l

0.18

189

759

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

204

846

2.41

29.74

1.5

1.2

137.60

55.99

u/l

3.88

195

744

Provisional assignment of new diseases of uncertain etiology

418

2290

1.83

29.70

1.3

1.2

66.22

62.01

u/l

0.28

392

2040

L04AC Interleukin inhibitors

175

4.39

29.60

1.1

48.47

58.87

u/l

1.12

162

Gastroduodenal ulcer

222

968

2.31

29.53

1.2

56.38

66.12

u/l

1.62

200

856

881

2947

1.55

29.52

1.2

59.40

63.95

u/l

1.02

800

2645

Sequelae of external causes of morbidity and mortality

239

1079

2.24

29.52

1.3

1.2

66.91

64.21

u/l

0.19

219

950

Other disorders of glucose regulation and pancreatic internal secretion

246

3.77

29.33

1.4

1.1

60.17

78.20

u/l

0.83

225

Other/unspecified seropositive rheumatoid arthritis

261

1226

2.15

29.21

1.2

54.83

60.78

u/l

1.40

239

1094

Intestinal stricture

278

1339

2.10

29.10

1.3

1.2

59.08

63.14

u/l

0.63

256

1175

Headache

459

2060

1.79

29.00

1.2

57.86

63.78

u/l

1.14

412

1842

Seropositive rheumatoid arthritis, wide

263

1243

2.14

28.98

1.2

55.07

60.61

u/l

1.27

241

1110

Syncope and collapse

335

1464

1.97

28.94

1.2

61.04

65.55

u/l

0.36

306

1298

AV-block

152

487

2.76

28.71

1.2

55.41

68.41

u/l

1.74

143

436

Symptoms and signs concerning food and fluid intake

103

306

3.41

28.69

1.2

62.74

68.79

u/l

0.27

272

Other cataract

383

1542

1.89

28.66

1.3

1.2

65.85

64.30

u/l

0.11

348

1357

Obesity due to excess calories

371

1989

1.88

28.46

1.2

58.19

63.06

u/l

0.81

338

1785

Mood disorders

785

3266

1.56

28.46

1.2

57.71

63.83

u/l

2.28

701

2942

Spondylopathies

631

2291

1.65

28.43

1.2

57.64

62.86

u/l

1.28

560

2056

Mood [affective] disorders

783

3262

1.56

28.43

1.2

57.76

63.83

u/l

2.25

699

2939

Statin medication

525

1700

1.74

28.40

1.2

66.92

62.58

u/l

0.30

469

1556

Acute pancreatitis

173

691

2.53

28.22

1.2

57.19

69.09

u/l

1.88

157

616

Benign neoplasm: Colon

454

2473

1.77

28.17

1.2

56.35

62.93

u/l

1.38

411

2195

Cystitis

666

2450

1.62

27.93

1.2

62.46

63.85

u/l

0.11

584

2223

ILD, hospital admission 2, with pulmonary infections

293

3.44

27.86

1.2

60.65

66.61

u/l

0.38

259

Disorders of the thyroid gland

716

2953

1.59

27.76

1.2

60.59

62.41

u/l

0.29

643

2655

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

254

1206

2.13

27.69

1.2

55.40

60.94

u/l

1.23

232

1076

Diabetic maculopathy

141

482

2.81

27.62

1.3

1.2

64.78

62.37

u/l

0.16

126

430

Other disorders of white blood cells

168

4.34

27.56

1.1

1.2

91.52

60.02

u/l

0.41

156

Diverticular disease of intestine

563

2146

1.68

27.56

1.2

54.82

64.08

u/l

2.31

500

1916

Other disorders of skin and subcutaneous tissue, not elsewhere classified

140

510

2.78

27.52

1.2

1.1

51.59

62.73

u/l

1.88

134

454

Mood disorders, excluding more controls

723

2737

1.58

27.42

1.2

56.99

61.95

u/l

1.58

643

2474

Enlarged lymph nodes

144

533

2.73

27.41

1.2

85.35

69.12

u/l

0.29

136

474

Hard cardiovascular diseases

664

2462

1.62

27.35

1.2

68.35

64.54

u/l

0.26

611

2199

Mycoses

235

1090

2.18

27.18

1.3

1.2

69.20

63.94

u/l

0.45

217

961

Asthma, hospital admissions 3, pneumonia

308

1575

1.97

27.13

1.2

59.32

65.04

u/l

0.74

282

1397

Asthma-related pneumonia or sepsis

308

1575

1.97

27.13

1.2

59.32

65.04

u/l

0.74

282

1397

Viral pneumonia (unknown virus, not influenza)

187

4.09

27.11

1.3

1.2

67.33

63.45

u/l

0.17

173

Presence of cardiac and vascular implants and grafts

340

1316

1.93

27.03

1.2

56.90

66.21

u/l

1.05

314

1153

Diabetic neuropathy

132

469

2.86

27.00

1.3

1.2

59.20

62.48

u/l

0.25

122

421

Personal history of malignant neoplasm

242

3.68

26.99

1.2

1.1

58.17

59.85

u/l

0.15

219

Asthma-related pneumonia

307

1572

1.96

26.95

1.2

59.35

65.12

u/l

0.75

281

1394

Volume depletion

275

3.47

26.93

1.3

1.2

68.65

66.34

u/l

0.09

239

Cough

338

1691

1.90

26.85

1.2

60.27

69.24

u/l

1.44

311

1501

ILD, hospital admissions 3, with pneumonia sepsis

257

3.57

26.80

1.2

61.21

66.86

u/l

0.33

231

Total colectomy operation

127

4.87

26.78

1.6

1.2

57.10

56.80

u/l

0.01

119

Total colectomy

127

4.87

26.78

1.6

1.2

57.10

56.80

u/l

0.01

119

UC patients in KELA-register (code 208), prior to 1994

139

4.67

26.76

1.4

1.2

67.70

60.89

u/l

0.32

129

Use of hypnotics and sedatives

804

3011

1.54

26.74

1.2

65.51

62.98

u/l

0.27

711

2723

Abnormal findings on diagnostic imaging of lung

394

2101

1.81

26.69

1.2

60.32

62.72

u/l

0.24

364

1863

Osteonecrosis

194

4.01

26.66

1.3

1.2

76.81

57.73

u/l

0.75

182

Other or unspecified ileus, impaction or obstruction

164

661

2.51

26.26

1.4

1.2

57.69

64.36

u/l

0.83

149

578

Dorsalgia

733

2512

1.57

26.17

1.2

55.44

64.76

u/l

4.01

662

2261

Injuries to the abdomen, lower back, lumbar spine and pelvis

315

1630

1.93

26.07

1.2

74.42

63.11

u/l

0.47

288

1441

Immunodeficiencies

142

4.56

26.04

1.3

1.2

116.54

60.39

u/l

0.48

132

Asthma, hospital admission 2, infections

457

2619

1.72

26.00

1.2

57.93

66.72

u/l

2.08

419

2338

Asthma-related infections

457

2619

1.72

26.00

1.2

57.93

66.72

u/l

2.08

419

2338

Anxiety disorders, excluding more controls

628

2549

1.61

25.99

1.2

65.37

62.42

u/l

0.35

568

2297

Care involving use of rehabilitation procedures

467

2523

1.71

25.94

1.2

71.86

61.40

u/l

0.62

415

2229

Other CVD

175

732

2.42

25.88

1.3

1.2

59.61

64.53

u/l

0.52

155

655

Psoriasis

251

1218

2.08

25.83

1.2

59.28

65.63

u/l

0.88

229

1078

Sequelae with surgical and medical care as external cause

191

832

2.32

25.80

1.3

1.2

65.54

65.88

u/l

0.02

175

740

Percutaneous Coronary Intervention

634

2431

1.61

25.69

1.2

67.81

64.73

u/l

0.19

577

2177

Diseases of the eye and adnexa

566

1703

1.67

25.63

1.2

66.60

68.94

u/l

0.15

514

1540

Emergency coronary revascularization (for ACS)

677

2617

1.58

25.57

1.2

67.35

66.02

u/l

0.08

614

2340

Senile cataract

512

1861

1.70

25.52

1.3

1.2

60.69

62.93

u/l

0.25

477

1645

Other diseases of arteries and capillaries

300

3.29

25.51

1.3

1.1

60.36

61.71

u/l

0.08

273

Type 1 diabetes, definitions combined

213

3.74

25.43

1.3

1.2

63.84

75.06

u/l

0.69

197

Ischemic heart diseases

658

2498

1.59

25.42

1.2

67.62

64.33

u/l

0.22

599

2239

Hypertensive Heart Disease

187

622

2.38

25.38

1.2

52.54

72.65

u/l

2.37

169

556

Hydronephrosis

100

316

3.21

25.33

1.2

76.78

62.83

u/l

0.58

277

Other diseases of stomach and duodenum

197

3.89

25.28

1.2

51.44

64.75

u/l

1.44

175

Irritable bowel syndrome

231

1096

2.13

25.22

1.1

1.2

54.42

60.87

u/l

1.42

205

984

Other reaction to severe stress, and adjustment disorders

287

1473

1.96

25.20

1.3

1.2

69.67

60.57

u/l

0.96

270

1329

Other respiratory diseases principally affecting the interstitium

164

678

2.45

24.94

1.2

61.09

66.86

u/l

0.55

149

604

Type 1 diabetes, strict (exclude DM2)

216

3.69

24.93

1.3

1.2

63.84

96.73

u/l

1.07

200

Chronic ulcer of skin, not elsewhere classified

204

3.80

24.83

1.2

54.07

67.75

u/l

1.03

184

Periodontitis

741

3254

1.53

24.71

1.2

65.71

60.73

u/l

0.44

669

2919

Hypercalcemia

149

4.36

24.56

1.4

1.2

59.22

52.44

u/l

0.61

137

Gingivitis and periodontal diseases

762

2576

1.53

24.35

1.2

61.77

62.55

u/l

0.09

689

2301

Spondylopathies (FG)

115

403

2.89

24.33

1.2

52.49

63.53

u/l

1.60

109

361

Idiopathic gout

279

3.32

24.29

1.2

55.66

64.96

u/l

0.68

249

Hypothyroidism, other/unspecified

665

2813

1.56

24.28

1.2

59.66

61.43

u/l

0.31

596

2531

Coronary revascularization (ANGIO or CABG)

627

2431

1.59

24.17

1.2

68.00

64.73

u/l

0.20

571

2177

Exclusions for E4_PCOS_BROAD

149

598

2.52

24.11

1.2

67.56

75.20

u/l

0.36

136

541

Methotrexate

132

500

2.67

24.10

1.1

59.50

63.28

u/l

0.24

123

439

Depression or dysthymia

521

1730

1.67

24.08

1.2

60.89

63.73

u/l

0.30

464

1563

Viral infections characterized by skin and mucous membrane lesions

640

3533

1.55

24.01

1.2

60.47

65.81

u/l

1.00

580

3175

Hypothyreosis and Thyroxine purchase for inclusion criteria

694

2964

1.54

24.00

1.2

59.55

61.71

u/l

0.42

623

2664

Papulosquamous disorders

324

1761

1.85

23.95

1.2

57.87

64.11

u/l

1.22

296

1561

Any death

499

2161

1.66

23.93

1.3

1.2

77.61

58.45

u/l

3.22

467

1900

Bronchitis

796

3357

1.50

23.93

1.2

59.91

63.16

u/l

0.63

724

3015

Benign neoplasm of other and ill-defined parts of digestive system

174

753

2.34

23.93

1.2

55.20

61.65

u/l

1.01

162

670

Vitamin B12 deficiency anaemia

101

333

3.08

23.86

1.3

1.2

54.21

63.23

u/l

1.08

299

Chronic periodontitis, including avohilmo

734

3259

1.52

23.53

1.3

1.2

65.94

60.64

u/l

0.47

662

2924

Elevated blood glucose level

226

3.55

23.49

1.1

1.2

58.36

62.48

u/l

0.24

205

Malignant neoplasm of breast, HER-negative

185

812

2.26

23.45

1.2

1.1

56.79

57.24

u/l

0.06

165

712

Pain (limb, back, neck, head abdominally)

501

1497

1.68

23.36

1.2

68.50

69.49

u/l

0.05

450

1347

Falls/tendency to fall

778

2589

1.51

23.14

1.2

64.26

65.72

u/l

0.18

688

2348

Invasive ventilation

220

3.57

22.98

1.2

71.01

65.88

u/l

0.17

200

Recurrent or chronic depression

317

1194

1.88

22.98

1.2

57.74

62.11

u/l

0.76

285

1085

Postmenopausal osteoporosis with pathological fracture

235

3.49

22.94

1.2

63.84

60.17

u/l

0.27

211

Symptoms and signs involving the urinary system

579

2804

1.58

22.91

1.2

65.69

63.31

u/l

0.23

520

2504

Gastric ulcer

153

638

2.42

22.85

1.2

56.54

68.55

u/l

1.56

142

563

Postprocedural disorders of digestive system, not elsewhere classified

101

5.01

22.61

1.5

1.2

59.26

52.52

u/l

0.47

Acute bronchitis

316

1700

1.83

22.57

1.2

67.15

65.24

u/l

0.11

287

1517

Diaphragmatic hernia

311

1702

1.84

22.54

1.2

60.68

60.88

u/l

0.01

272

1519

Myocardial infarction

377

1510

1.77

22.44

1.2

58.19

62.67

u/l

0.80

337

1337

Neurotic, stress-related and somatoform disorders

658

3016

1.53

22.42

1.2

65.81

64.25

u/l

0.16

596

2708

Disorder of lipoprotein metabolism, unspecified

118

439

2.72

22.37

1.2

49.06

65.38

u/l

2.85

107

385

Viral and other specified intestinal infections

140

551

2.50

22.34

1.3

1.2

76.83

72.23

u/l

0.10

133

497

Other acute lower respiratory infections

388

2163

1.72

22.13

1.2

64.61

66.16

u/l

0.11

351

1941

Vocal cord dysfunction

100

303

2.99

22.05

1.2

54.79

70.26

u/l

2.07

270

Benign neoplasms

678

2449

1.53

22.02

1.2

61.82

66.62

u/l

0.69

604

2215

Anxiety disorders

663

3045

1.52

21.97

1.2

65.60

64.20

u/l

0.15

601

2734

Acute pancreatitis (for exclusion)

173

775

2.26

21.94

1.2

57.19

64.63

u/l

1.07

157

690

Sleep disorders (combined)

830

2974

1.47

21.92

1.2

61.23

64.49

u/l

0.60

740

2683

Viral and other specified intestinal infections

184

814

2.19

21.80

1.3

1.2

71.85

67.12

u/l

0.13

171

729

Soft tissue disorders

714

2434

1.52

21.79

1.2

62.31

68.83

u/l

1.05

643

2183

Conduction disorders

223

884

2.06

21.68

1.1

1.2

65.96

71.27

u/l

0.31

208

782

Other joint disorders

589

1976

1.58

21.61

1.2

57.65

72.23

u/l

3.19

532

1785

Diseases of the musculoskeletal system and connective tissue

337

918

1.85

21.59

1.2

73.06

75.52

u/l

0.11

302

824

Malignant neoplasm of breast, ER-negative, including Hilmo

196

884

2.13

21.47

1.2

1.1

56.59

56.97

u/l

0.05

175

775

Open wound of ankle and foot

317

3.01

21.40

1.3

1.2

59.53

65.67

u/l

0.29

283

Major coronary heart disease event

648

2572

1.53

21.17

1.2

67.27

64.68

u/l

0.16

589

2296

Obesity, other/unspecified

267

1421

1.89

21.15

1.2

58.07

60.89

u/l

0.37

249

1272

Seronegative rheumatoid arthritis

108

397

2.76

20.99

1.1

56.00

63.42

u/l

0.79

349

Hypoglycaemia, other or unspecified

195

3.60

20.95

1.4

1.1

56.82

80.17

u/l

0.94

179

Other special examinations and investigations of persons without complaint or reported diagnosis

432

1295

1.70

20.83

1.2

63.63

68.80

u/l

0.48

395

1145

STROKE

413

1678

1.68

20.58

1.2

59.96

63.28

u/l

0.49

377

1490

All influenza (not pneumonia)

114

436

2.64

20.47

1.3

1.1

67.52

64.99

u/l

0.13

108

393

Symptoms and signs involving cognition, perception, emotional state and behaviour

709

3278

1.48

20.43

1.2

60.70

64.27

u/l

0.54

631

2957

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

166

3.80

20.39

1.1

1.2

57.98

53.24

u/l

0.29

146

Weight loss

333

2.90

20.23

1.2

57.20

69.20

u/l

0.79

301

Exposure to other specified factors

540

3219

1.55

20.10

1.2

60.62

64.73

u/l

0.75

480

2902

Bacterial pneumoniae

292

1424

1.82

20.03

1.3

1.2

59.39

62.04

u/l

0.28

277

1259

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

712

3104

1.47

19.93

1.2

62.75

61.40

u/l

0.09

636

2794

Mycoses

615

3573

1.50

19.89

1.2

68.52

62.86

u/l

0.62

554

3216

Type 2 diabetes, definitions combined, including avohilmo

677

2649

1.49

19.85

1.2

58.67

63.10

u/l

0.84

610

2377

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

136

556

2.40

19.81

1.3

1.2

99.34

75.72

u/l

0.39

121

507

Diseases of the respiratory system

467

1435

1.64

19.73

1.2

62.44

68.41

u/l

0.70

429

1270

Type 2 diabetes, definitions combined

670

2642

1.49

19.72

1.2

59.02

62.69

u/l

0.64

607

2368

Hypotension

139

596

2.36

19.59

1.3

1.2

61.69

64.61

u/l

0.22

123

532

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

129

517

2.44

19.56

1.3

1.2

101.82

77.37

u/l

0.38

115

471

General examination and investigation of persons without complaint and reported diagnosis

415

1294

1.68

19.54

1.2

64.77

68.82

u/l

0.36

390

1144

Disorders of continuity of bone

323

2.89

19.54

1.3

1.1

67.49

56.88

u/l

1.00

296

Sleep apnoea

698

3081

1.47

19.45

1.2

59.92

63.78

u/l

0.70

625

2765

Type 2 diabetes, strict (exclude DM1)

675

2674

1.49

19.44

1.2

59.12

63.30

u/l

0.76

611

2396

Abnormal findings on diagnostic imaging of other body structures

127

526

2.45

19.38

1.2

59.43

61.74

u/l

0.14

114

472

Asthma (diagnoses ohter than nonallergic)

630

3523

1.49

19.36

1.2

56.43

65.19

u/l

2.88

569

3168

Dipeptidyl peptidase 4 (DPP-4) inhibitors

437

2174

1.62

19.34

1.2

56.54

62.61

u/l

1.30

390

1941

325

1873

1.73

19.23

1.3

1.2

57.98

69.30

u/l

2.09

300

1667

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

275

1525

1.82

19.18

1.2

66.52

62.14

u/l

0.48

247

1364

Other (not insulin) diabetes medications

695

2808

1.47

19.16

1.2

58.97

62.84

u/l

0.73

626

2520

Other pleural conditions

332

2.84

19.16

1.2

62.41

64.83

u/l

0.09

295

Diagnoses used for exclusion with ILD

207

1047

1.99

19.15

1.2

51.65

64.63

u/l

3.14

193

926

Abnormal weight loss

295

2.96

19.07

1.2

57.24

68.36

u/l

0.64

268

Candidiasis

228

1195

1.92

19.01

1.2

62.81

62.02

u/l

0.07

202

1064

Cardiomyopathy

129

544

2.39

18.88

1.2

75.23

68.49

u/l

0.12

117

480

Cardiodefibrillation

271

1500

1.82

18.87

1.2

54.22

66.34

u/l

2.22

234

1334

Other and unspecified disorders of white blood cells

126

4.15

18.82

1.1

1.2

58.70

52.74

u/l

0.46

117

Chronic periodontitis, complicated

417

2578

1.61

18.78

1.3

1.2

69.94

61.42

u/l

0.44

377

2299

Nerve, nerve root and plexus disorders

767

3278

1.44

18.75

1.2

59.07

62.58

u/l

0.72

702

2941

Anxiety (asthma-related co-morbidities)

421

2019

1.62

18.67

1.2

63.78

66.93

u/l

0.29

377

1827

Sleep apnoea, including avohilmo

730

3130

1.45

18.67

1.2

60.01

63.98

u/l

0.76

655

2811

Sicca syndrome [Sjögren]

332

2.82

18.63

1.2

1.1

53.57

57.86

u/l

0.44

303

Thyrotoxicosis, other and/or unspecified

173

830

2.10

18.54

1.2

76.85

62.09

u/l

1.42

151

743

Intracranial trauma

397

1701

1.65

18.53

1.2

61.34

69.67

u/l

1.15

351

1537

ILD, hospital admissions

129

550

2.37

18.48

1.2

61.87

66.78

u/l

0.38

119

490

Any mental disorder

792

2776

1.43

18.29

1.2

66.25

63.35

u/l

0.28

704

2510

Persons encountering health services for examination and investigation

423

1295

1.64

18.22

1.2

66.03

68.80

u/l

0.20

387

1145

Candidiasis

120

499

2.43

18.18

1.3

1.2

62.94

61.90

u/l

0.05

107

454

Other metabolic disorders

118

487

2.45

18.17

1.2

78.55

56.30

u/l

1.99

112

438

Operations 2 for CAVS

221

1127

1.92

18.15

1.2

52.01

64.12

u/l

2.69

203

997

Calcific aortic valvular stenosis, diagnosis (helper)

221

1127

1.92

18.15

1.2

52.01

64.12

u/l

2.69

203

997

Calcific aortic valvular stenosis, including rheumatic fever

222

1133

1.91

18.13

1.2

51.83

64.04

u/l

2.74

204

1003

Other interstitial pulmonary diseases

130

561

2.34

18.12

1.2

61.66

66.50

u/l

0.38

120

501

Genitourinary diseases

348

1012

1.73

18.10

1.2

76.37

74.14

u/l

0.08

314

903

Interstitial lung disease

130

562

2.34

18.05

1.2

61.66

66.40

u/l

0.37

120

502

Interstitial lung disease endpoints

130

562

2.34

18.05

1.2

61.66

66.40

u/l

0.37

120

502

Other diseases of anus and rectum

229

1220

1.89

18.05

1.2

53.09

64.83

u/l

3.32

201

1088

Calcific aortic valvular stenosis

221

1130

1.91

18.01

1.2

52.01

64.43

u/l

2.79

203

1000

Calcific aortic valvular stenosis, operated

221

1130

1.91

18.01

1.2

52.01

64.43

u/l

2.79

203

1000

Major coronary heart disease event excluding revascularizations

447

1879

1.59

18.00

1.2

56.40

62.44

u/l

1.49

404

1662

Bacterial pneumonia, not elsewhere classified

274

1354

1.79

17.99

1.3

1.2

57.97

62.14

u/l

0.52

260

1194

Chronic lower respiratory diseases

851

3231

1.41

17.97

1.2

57.15

67.89

u/l

3.81

771

2909

Myocardial infarction, without ST-elevation

298

1567

1.74

17.90

1.2

57.70

64.17

u/l

0.99

272

1383

Other external causes of accidental injury

572

1888

1.52

17.88

1.2

64.37

67.56

u/l

0.34

509

1729

Fracture of rib(s), sternum and thoracic spine

224

1192

1.89

17.86

1.2

69.47

61.92

u/l

0.70

194

1056

Malignant neoplasm of prostate

174

487

2.15

17.79

1.5

1.2

98.16

54.82

u/l

2.45

155

429

Diseases of pulp and periapical tissues, including avohilmo

739

2663

1.44

17.78

1.2

63.84

64.29

u/l

0.04

662

2400

Unspecified haematuria

304

1459

1.74

17.76

1.2

64.77

66.64

u/l

0.12

274

1295

Acute upper respiratory infections of multiple and unspecified sites

530

2596

1.52

17.68

1.2

58.55

65.30

u/l

1.51

486

2325

Thyrotoxicosis

217

1148

1.91

17.65

1.2

72.38

60.95

u/l

1.36

191

1029

Injuries to the thorax

325

1937

1.69

17.56

1.2

69.46

60.74

u/l

1.20

289

1728

Disorders of synovium and tendon

384

2082

1.62

17.54

1.2

60.20

62.63

u/l

0.39

347

1857

Symptoms and signs involving the skin and subcutaneous tissue

516

3354

1.51

17.54

1.2

59.55

63.16

u/l

0.55

478

2995

Intestinal malabsorption

151

3.72

17.53

1.4

1.2

52.87

60.46

u/l

0.52

143

ILD, hospital admissions 1, main diag only

116

486

2.42

17.32

1.1

1.2

63.98

64.88

u/l

0.05

107

433

Coronary atherosclerosis

484

1985

1.55

17.20

1.2

57.75

62.10

u/l

0.89

437

1761

Myocardial infarction, strict

335

1421

1.69

17.18

1.2

58.65

63.31

u/l

0.69

298

1265

Disorders of vitreous body and globe

409

2496

1.58

17.04

1.2

59.23

61.69

u/l

0.36

368

2221

Cardiomyopathy, other and unspecified

213

3.19

16.97

1.1

1.2

64.23

62.76

u/l

0.03

193

malignant neoplasm of male genital organs

177

519

2.09

16.96

1.5

1.2

97.79

54.60

u/l

2.51

158

455

Disorders of vitreous body

400

2448

1.59

16.89

1.2

59.48

61.47

u/l

0.27

361

2175

All anxiety disorders

424

2135

1.58

16.88

1.2

63.65

65.11

u/l

0.12

380

1925

Secondary and unspecified malignant neoplasm of lymph nodes

235

3.06

16.80

1.2

1.1

54.55

55.61

u/l

0.07

210

Congenital malformations, deformations and chromosomal abnormalities

398

2405

1.58

16.62

1.3

1.2

59.58

66.06

u/l

1.34

359

2168

Neurological diseases, wide definition

156

353

2.23

16.60

1.2

76.81

90.53

u/l

0.37

148

321

Injuries to the head

776

3419

1.40

16.42

1.2

61.86

65.37

u/l

0.51

672

3105

Gonarthrosis [arthrosis of knee](FG)

514

1978

1.52

16.33

1.2

59.12

64.99

u/l

0.93

457

1772

L02BA Anti-estrogens

160

785

2.06

16.26

1.2

59.40

59.68

u/l

0.03

149

701

Thyroiditis, ILD-related definition

362

2.60

16.25

1.2

54.18

63.48

u/l

1.13

327

Ischaemic heart disease, wide definition

580

2449

1.47

16.19

1.2

57.43

63.29

u/l

1.60

524

2186

Acute upper respiratory infections

743

3266

1.41

16.15

1.2

56.97

64.64

u/l

2.42

678

2930

Alcohol use disorder, Swedish definition

369

2122

1.60

16.12

1.2

61.91

62.56

u/l

0.04

321

1914

Persons with potential health hazards related to communicable diseases

246

1379

1.78

16.10

1.3

1.2

73.51

66.00

u/l

0.28

215

1255

Early onset COPD, excluding more controls

146

694

2.12

16.06

1.1

1.2

57.94

64.25

u/l

0.47

130

607

Bacterial pneumonia (organism specified)

317

1739

1.66

16.02

1.3

1.2

59.34

64.36

u/l

0.62

302

1540

Retention of urine

232

1051

1.82

15.98

1.2

66.29

69.15

u/l

0.14

211

941

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

110

4.07

15.98

1.0

1.1

56.05

52.44

u/l

0.15

Sarcoidosis

115

498

2.34

15.97

1.2

53.91

60.11

u/l

0.67

108

452

Paroxysmal tachycardia

150

599

2.11

15.82

1.4

1.2

63.93

62.86

u/l

0.04

139

536

Other (seronegative) rheumatoid arthritis, wide

165

827

2.01

15.81

1.2

54.79

61.87

u/l

1.21

150

730

Other arrhythmias

435

2133

1.54

15.80

1.2

65.02

64.52

u/l

0.02

392

1910

Cholecystitis

109

463

2.38

15.80

1.3

1.2

56.28

63.63

u/l

0.91

100

413

Seropositive rheumatoid arthritis, strict definition

133

615

2.19

15.79

1.2

56.00

62.15

u/l

0.80

122

555

Intestinal adhesions without obstruction

271

2.84

15.78

1.2

52.15

61.89

u/l

1.07

245

Other local infections of skin and subcutaneous tissue

327

2.66

15.77

1.3

1.1

62.12

73.95

u/l

0.58

295

Accidents

559

1888

1.49

15.75

1.2

64.18

67.56

u/l

0.36

498

1729

Non-selective monoamine reuptake inhibitors

295

1701

1.68

15.73

1.1

1.2

53.32

62.47

u/l

3.08

266

1519

Gingival hyperplasia

116

3.98

15.73

1.4

1.2

129.49

62.03

u/l

0.59

110

Other dorsopathies, not elsewhere classified

684

2518

1.43

15.63

1.2

57.29

64.82

u/l

2.31

620

2266

Colectomy operation

140

665

2.13

15.52

1.3

1.2

64.84

61.16

u/l

0.21

123

596

Postprocedural endocrine and metabolic disorders, not elsewhere classified

107

455

2.38

15.50

1.2

73.18

55.80

u/l

1.41

101

410

Trigger finger

129

594

2.19

15.48

1.3

1.2

56.50

60.80

u/l

0.49

116

533

Pruritus

377

2.52

15.47

1.2

57.95

67.21

u/l

0.81

340

Other and unspecified local infections of skin and subcutaneous tissue

302

2.72

15.45

1.3

1.1

62.86

74.22

u/l

0.50

273

Zoster [herpes zoster]

374

2348

1.58

15.43

1.2

57.38

62.16

u/l

1.00

333

2090

Psoriasis vulgaris

148

723

2.07

15.22

1.2

56.67

64.85

u/l

1.08

134

644

Congenital malformations, deformations and chromosomal abnormalities

433

2634

1.52

15.11

1.3

1.2

58.59

65.30

u/l

1.58

390

2364

Open wound of lower leg

116

518

2.26

15.00

1.3

1.2

99.74

65.25

u/l

0.53

103

467

Concussion

331

1678

1.62

14.83

1.2

61.09

69.84

u/l

1.24

295

1517

Disorders of sclera, cornea, iris and ciliary body

385

2497

1.55

14.81

1.2

53.94

63.49

u/l

3.50

362

2222

Tubulo-interstitial nephritis, not specified as acute or chronic

180

3.21

14.64

1.3

1.2

60.99

62.54

u/l

0.06

164

Ankylosing spondylitis, ICD10

272

2.76

14.54

1.1

1.2

54.73

65.58

u/l

0.94

248

Factors influencing health status and contact with health services

177

446

2.00

14.46

1.2

1.1

62.74

72.52

u/l

0.45

162

387

381

2232

1.55

14.46

1.2

62.87

64.60

u/l

0.13

333

2017

Hypothyroidism, strict autoimmune, 3 medication purchases required

592

2814

1.43

14.23

1.2

56.83

61.81

u/l

1.45

529

2526

Secondary uncertain malignant neoplasm

393

2.41

14.17

1.2

1.1

76.87

57.77

u/l

0.96

347

Pulmonary heart disease, diseases of pulmonary circulation

238

1389

1.72

14.06

1.2

63.79

63.44

u/l

0.02

216

1223

398

2309

1.52

14.00

1.2

63.12

64.32

u/l

0.09

348

2086

Dorsopathies

691

2527

1.39

13.88

1.2

60.30

65.18

u/l

1.05

624

2275

Other anxiety disorders

300

1609

1.62

13.83

1.2

64.90

64.87

u/l

0.00

266

1458

Substance abuse, excluding more controls

362

1998

1.55

13.73

1.2

64.26

63.59

u/l

0.04

318

1807

Disorders of skin appendages

325

2065

1.58

13.66

1.2

66.63

64.34

u/l

0.18

299

1847

Malignant neoplasm of digestive organs

246

1142

1.71

13.62

1.1

75.00

57.17

u/l

1.47

226

1005

Thyrotoxicosis with diffuse goitre

118

553

2.15

13.61

1.2

81.05

58.03

u/l

2.31

106

502

Valvular operations

413

2.34

13.58

1.3

1.2

81.48

71.48

u/l

0.10

370

Viral infections characterized by skin and mucous membrane lesions

293

1821

1.62

13.56

1.2

63.08

66.39

u/l

0.34

277

1614

Selective serotonin reuptake inhibitors

671

2522

1.39

13.52

1.2

60.91

65.31

u/l

0.62

590

2286

Degeneration of macula and posterior pole

341

1738

1.57

13.47

1.2

56.09

63.19

u/l

1.25

301

1553

Malignant neoplasm of prostate, including Hilmo

166

506

1.96

13.44

1.5

1.2

101.41

54.80

u/l

2.52

146

444

COPD (mode)

205

903

1.79

13.41

1.2

49.43

67.47

u/l

3.04

182

784

Asthma, including avohilmo

808

3379

1.35

13.39

1.2

56.98

67.36

u/l

3.67

732

3042

Psoriatic arthropathies

355

2.45

13.38

1.2

62.07

63.81

u/l

0.09

313

Acute posthaemorrhagic anaemia

4.12

13.33

1.7

1.1

70.00

55.31

u/l

0.93

Episodal and paroxysmal disorders

749

2804

1.36

13.18

1.2

59.88

68.07

u/l

1.64

670

2523

Dental caries, including avohilmo

510

1795

1.46

13.17

1.2

73.28

62.07

u/l

1.02

459

1626

Lichen simplex chronicus and prurigo

203

2.95

13.16

1.2

51.37

65.79

u/l

1.39

185

Coxarthrosis [arthrosis of hip](FG)

368

1689

1.54

13.12

1.2

59.65

64.19

u/l

0.55

331

1508

Personality disorders, excluding more controls

165

882

1.88

13.11

1.2

55.84

59.59

u/l

0.44

144

805

Disorders of conjunctiva

567

3252

1.40

12.93

1.2

59.28

65.82

u/l

1.31

527

2905

External causes of morbidity and mortality

435

1458

1.50

12.87

1.2

63.60

67.72

u/l

0.37

390

1327

Carbimazole or st.post thyroidectomy, condition for graves disease

167

905

1.86

12.78

1.1

1.2

75.24

58.39

u/l

2.27

150

814

Ankylosing spondylitis

297

2.55

12.76

1.1

54.69

67.89

u/l

1.26

259

Urticaria and erythema

259

1588

1.64

12.74

1.2

68.11

64.40

u/l

0.10

236

1418

Functional dyspepsia

193

1095

1.77

12.67

1.2

53.16

64.56

u/l

2.41

170

979

Other/unspecified dorsalgia

268

1646

1.62

12.63

1.2

59.00

62.16

u/l

0.41

242

1457

Benign neoplasm: Colon, unspecified

188

1065

1.78

12.44

1.2

52.76

64.39

u/l

2.70

168

937

Arthropathic psoriasis

411

2.29

12.44

1.2

60.69

62.20

u/l

0.09

372

Nonorganic sleeping disorders, excluding more controls

128

640

2.01

12.43

1.1

1.2

69.08

58.73

u/l

0.98

114

582

Neurological diseases

564

2008

1.41

12.41

1.2

66.71

71.14

u/l

0.41

507

1815

Other and unspecified psoriasis

210

2.85

12.39

1.2

61.77

60.07

u/l

0.07

193

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

108

509

2.14

12.32

1.2

57.26

58.05

u/l

0.05

448

Injuries to the knee and lower leg

807

3381

1.33

12.22

1.2

64.04

65.01

u/l

0.07

729

3041

Acute sinusitis

340

2071

1.53

12.20

1.3

1.2

58.35

65.04

u/l

1.53

317

1860

Etanercept

196

2.90

12.13

1.1

55.10

66.67

u/l

0.70

181

Other diseases of hard tissues of teeth

388

1332

1.51

12.06

1.2

66.44

59.75

u/l

0.77

352

1193

Misadventures to patients during surgical and medical care

111

534

2.10

12.02

1.2

1.1

49.15

62.96

u/l

2.43

102

482

Other general symptoms and signs

124

3.40

11.87

1.1

1.2

72.71

64.33

u/l

0.20

116

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

326

2.42

11.87

1.2

67.18

70.79

u/l

0.13

296

Open wound of head

353

2275

1.50

11.82

1.2

57.48

66.63

u/l

1.84

308

2053

Other respiratory disorders and diseases

147

786

1.88

11.76

1.2

87.59

67.91

u/l

0.35

131

700

Other diseases of the respiratory system

147

786

1.88

11.76

1.2

87.59

67.91

u/l

0.35

131

700

Bronchiectasis

274

2.55

11.73

1.3

1.1

54.53

64.83

u/l

1.20

242

Other/unspecified rheumatoid arthritis

102

480

2.15

11.72

1.1

1.2

55.47

62.69

u/l

0.90

434

Gonarthrosis

431

1682

1.46

11.72

1.2

59.37

67.14

u/l

1.14

383

1509

Venous thromboembolism

381

2507

1.47

11.65

1.2

62.38

60.59

u/l

0.21

349

2236

Arterial embolism and thrombosis

168

3.01

11.64

1.2

67.66

59.08

u/l

0.28

153

Diseases of oral cavity, salivary glands and jaws

390

1343

1.50

11.63

1.2

72.05

59.64

u/l

0.94

349

1204

Family history of malignant neoplasm

385

2.28

11.62

1.3

1.1

61.98

54.06

u/l

1.45

350

Fracture of lower leg, including ankle

388

2630

1.47

11.59

1.2

61.61

64.33

u/l

0.33

350

2340

Caries of dentine, including avohilmo

537

1955

1.41

11.55

1.2

70.81

65.68

u/l

0.46

477

1770

Pacemaker

222

1287

1.66

11.51

1.2

59.16

66.90

u/l

0.62

205

1138

Other coagulation defects

236

2.66

11.48

1.2

48.50

66.63

u/l

1.36

220

Myeloproliferative diseases

283

2.51

11.47

1.2

51.48

60.20

u/l

0.87

258

Malignant neoplasm of liver and intrahepatic bile ducts

4.59

11.46

1.0

1.1

47.41

46.90

u/l

0.02

Zoster [herpes zoster]

143

765

1.88

11.45

1.2

59.93

62.90

u/l

0.24

132

684

Injuries to the elbow and forearm

488

3061

1.41

11.45

1.2

66.25

63.42

u/l

0.38

425

2756

Myalgia

164

919

1.80

11.29

1.2

57.25

61.51

u/l

0.56

153

821

Psoriatic arthropathies, ICD10

385

2.26

11.21

1.2

62.07

60.56

u/l

0.08

352

Other disorders of lacrimal gland

265

1689

1.58

11.20

1.2

57.35

61.72

u/l

0.68

235

1514

Faecal incontinence

354

2.31

11.18

1.2

55.91

59.11

u/l

0.24

319

Arthrosis

458

1758

1.43

11.11

1.2

61.80

66.46

u/l

0.52

413

1578

Other psoriatic arthropathies

368

2.28

11.07

1.2

62.21

58.20

u/l

0.27

336

Hernia

641

3200

1.35

11.07

1.2

63.65

62.83

u/l

0.08

570

2881

Spondylosis

380

2123

1.46

11.03

1.2

58.86

63.13

u/l

0.76

326

1896

Unspecified fall

336

2227

1.49

11.01

1.2

72.87

64.46

u/l

0.34

307

1992

Exclusions for E4_PCOS_CONSORTIUM

499

2235

1.40

10.98

1.2

60.75

61.20

u/l

0.06

452

2014

Other follicular disorders

213

2.71

10.95

1.2

64.58

59.56

u/l

0.26

201

Cardiomyopathies, Primary/intrinsic

345

2.31

10.90

1.1

1.2

89.43

68.41

u/l

0.26

306

Other and unspecified disorders of skin and subcutaneous tissue

197

2.78

10.88

1.2

45.70

54.70

u/l

1.28

179

Persistent mood disorders

140

757

1.86

10.86

1.1

1.2

53.67

62.09

u/l

1.36

122

675

Oesophagitis

154

3.03

10.82

1.3

1.2

53.26

74.01

u/l

1.50

140

Disorders of eyelid, lacrimal system and orbit

589

3313

1.35

10.78

1.2

67.40

62.58

u/l

0.32

526

2980

Other abnormal findings of blood chemistry

129

3.23

10.71

1.2

55.08

52.57

u/l

0.15

121

Injuries to the ankle and foot

448

2835

1.41

10.69

1.3

1.2

57.85

67.34

u/l

1.99

397

2556

Dysphagia

166

950

1.76

10.67

1.3

1.2

80.03

66.56

u/l

0.26

150

838

Malignant melanoma, including Hilmo

116

593

1.97

10.67

1.2

57.87

56.83

u/l

0.05

108

522

Mental and behavioural disorders due to psychoactive substance use

377

2415

1.45

10.66

1.2

65.21

62.79

u/l

0.19

332

2182

Fracture of shoulder and upper arm

254

1621

1.57

10.63

1.2

61.05

65.76

u/l

0.68

228

1443

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

343

2.29

10.53

1.2

1.1

59.95

58.65

u/l

0.07

304

Fluid overload

26.33

10.53

1.5

1.3

101.71

30.83

u/l

—

Malignant neoplasm of skin

315

1432

1.51

10.48

1.3

1.2

56.68

56.58

u/l

0.01

281

1251

Injuries to unspecified part of trunk, limb or body region

314

2.35

10.46

1.3

1.2

61.31

65.61

u/l

0.18

288

Sciatica+with lumbago

345

2167

1.47

10.43

1.2

53.12

63.69

u/l

4.42

308

1944

Psychiatric diseases

664

2494

1.34

10.41

1.2

67.54

63.79

u/l

0.32

590

2251

Malignant melanoma

476

2.08

10.41

1.2

1.1

59.62

56.00

u/l

0.18

414

Reactive arthropathies

267

2.46

10.32

1.3

1.1

52.27

61.98

u/l

1.03

241

Fracture of forearm

394

2532

1.43

10.31

1.2

65.93

62.24

u/l

0.55

346

2277

Cardiomyopathy (excluding other)

368

2.22

10.20

1.1

1.2

88.60

68.27

u/l

0.25

323

Myeloproliferative diseases (CML excluded)

257

2.48

10.18

1.2

49.18

58.45

u/l

1.01

234

Conjunctivitis

500

3051

1.37

10.16

1.2

61.15

65.61

u/l

0.66

463

2730

Duodenal ulcer

337

2.27

10.15

1.2

57.26

71.46

u/l

1.19

299

Graves disease, strict definition

370

2.21

10.10

1.2

1.1

92.51

56.83

u/l

2.75

343

Substance abuse

362

2361

1.45

10.08

1.2

64.26

62.79

u/l

0.11

318

2132

In situ neoplasms

270

1775

1.53

9.99

1.2

58.40

61.44

u/l

0.35

249

1584

Asthma, hospital admissions , main diagnosis only

543

3560

1.35

9.97

1.2

57.55

65.46

u/l

2.18

498

3196

Biguanides

650

3002

1.32

9.89

1.2

58.65

62.86

u/l

0.82

584

2699

Hypopituitarism

190

2.71

9.89

1.2

64.57

80.87

u/l

0.53

175

Pulmonary embolism

206

1276

1.62

9.87

1.2

65.08

63.36

u/l

0.12

191

1120

Abnormalities of heart beat

233

1456

1.58

9.86

1.2

75.14

64.91

u/l

0.29

214

1291

Calculus of kidney and ureter

196

1200

1.64

9.85

1.2

68.66

61.39

u/l

0.52

175

1068

Cerebrovascular diseases

502

2583

1.37

9.84

1.2

58.56

62.29

u/l

0.64

450

2301

Stroke, excluding SAH

407

2104

1.42

9.80

1.2

59.59

62.52

u/l

0.38

365

1875

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

293

2.34

9.73

1.2

1.1

75.15

56.61

u/l

0.85

260

Familial hypercholesterolemia, with ischemic heart disease

312

2.30

9.73

1.2

58.50

69.03

u/l

0.71

276

Other infective otitis externa

187

2.71

9.65

1.3

1.2

47.64

60.49

u/l

1.27

172

Substance use, excluding alcohol

127

693

1.84

9.63

1.2

60.49

65.89

u/l

0.43

114

625

Missing teeth due to accident, extraction or parodontitis

412

2783

1.40

9.60

1.2

62.95

61.27

u/l

0.18

366

2472

Abnormalities of gait and mobility

444

2.07

9.60

1.2

99.65

71.62

u/l

0.28

401

Degenerative macular diseases

438

2.07

9.56

1.2

60.50

64.38

u/l

0.19

393

Other other unspecified disorders of the circulatory system

118

3.19

9.51

1.3

1.2

51.59

51.75

u/l

0.01

111

Pulmonary heart disease

206

1289

1.61

9.49

1.2

65.08

62.87

u/l

0.16

191

1130

Polymyalgia rheumatica

480

2.02

9.47

1.1

1.2

72.25

62.18

u/l

0.31

425

Dental operations

409

1481

1.42

9.47

1.2

69.08

62.78

u/l

0.39

373

1325

Cyst of kidney

218

2.55

9.46

1.2

56.38

62.05

u/l

0.35

198

Infection due to other mycobacteria

7.09

9.39

1.5

1.2

51.77

42.58

u/l

0.60

Coxarthrosis

330

1493

1.46

9.36

1.2

60.55

65.46

u/l

0.53

297

1337

Symptoms and signs involving the nervous and musculoskeletal systems

385

2744

1.41

9.36

1.2

70.10

63.26

u/l

0.30

342

2452

Familial hypercholesterolemia

100

510

1.97

9.33

1.2

63.91

67.03

u/l

0.17

446

Spinal stenosis

355

1883

1.44

9.32

1.2

56.78

61.54

u/l

0.96

315

1679

Other viral diseases

175

1054

1.66

9.28

1.2

68.89

69.84

u/l

0.05

164

951

Other diseases of oesophagus

287

2.32

9.27

1.3

1.2

121.50

67.85

u/l

0.46

257

Diseases of external ear

224

1439

1.56

9.24

1.2

66.17

67.36

u/l

0.07

205

1270

Fall involving bed

3.51

9.23

1.1

1.2

73.38

64.48

u/l

0.29

Malignant neoplasm of kidney, except renal pelvis

251

2.41

9.20

1.2

1.1

77.80

57.23

u/l

0.83

226

Benign neoplasm: Stomach

379

2.13

9.15

1.2

54.05

61.19

u/l

0.71

346

Urolithiasis

206

1301

1.59

9.15

1.2

68.70

61.99

u/l

0.49

183

1160

Dizziness and giddiness

504

2973

1.35

9.11

1.2

62.01

61.00

u/l

0.10

446

2679

Hernia of abdominal wall

293

1998

1.47

9.11

1.2

59.93

63.90

u/l

0.33

272

1770

Obesity related asthma

233

1517

1.54

9.06

1.2

57.78

62.69

u/l

0.64

208

1345

Phobic anxiety disorders

361

2.14

8.98

1.2

57.47

64.68

u/l

0.61

336

Cerebral palsy and other paralytic syndromes

375

2.12

8.98

1.4

1.2

64.23

67.61

u/l

0.12

338

Other intervertebral disc disorders

530

2382

1.34

8.98

1.2

58.92

62.81

u/l

0.65

472

2142

Intracranial injury

367

2474

1.41

8.89

1.2

62.68

64.26

u/l

0.16

323

2234

Diseases of pulp and periapical tissues and dental caries

430

1586

1.39

8.86

1.2

71.93

62.63

u/l

0.69

391

1430

Undetermined asthma, excluding more controls

424

2.04

8.82

1.3

1.1

55.18

64.93

u/l

1.10

374

Macular pucker

113

613

1.86

8.80

1.3

1.2

53.19

65.36

u/l

1.91

100

545

Chronic rhinitis, nasopharyngitis and pharyngitis

220

1424

1.55

8.80

1.3

1.2

54.07

65.04

u/l

2.90

193

1266

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

164

985

1.67

8.78

1.2

54.66

60.71

u/l

0.79

145

893

Shoulder lesions

485

2174

1.35

8.74

1.2

59.78

64.00

u/l

0.61

437

1939

Benign neoplasm: Transverse colon

393

2.08

8.73

1.3

1.2

54.31

63.65

u/l

0.97

352

Nonorganic sleeping disorders

128

724

1.78

8.67

1.1

1.2

69.08

65.56

u/l

0.20

114

660

Basal cell carcinoma

266

1231

1.50

8.63

1.2

56.69

57.13

u/l

0.05

240

1078

Other malignant neoplasms of skin (=non-melanoma skin cancer)

276

1275

1.49

8.63

1.2

55.62

57.11

u/l

0.20

246

1113

Secondary right heart disease

120

3.05

8.61

1.3

1.2

56.24

60.88

u/l

0.15

110

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

296

1372

1.47

8.61

1.3

1.2

57.51

56.79

u/l

0.09

262

1198

Keratitis

232

1529

1.52

8.56

1.2

57.14

64.10

u/l

1.42

218

1356

Non-allergic asthma (mode), excluding more controls

115

626

1.83

8.55

1.2

1.1

51.97

68.05

u/l

3.01

103

556

Basal cell carcinoma, including avohilmo

278

1295

1.48

8.55

1.2

55.75

57.12

u/l

0.19

251

1129

Malignant neoplasm of endocrine gland

218

2.46

8.47

1.2

1.1

82.29

58.37

u/l

0.88

195

Delirium, not induced by alcohol and other psychoactive substances

410

2.04

8.47

1.1

1.2

67.22

62.61

u/l

0.24

366

Amiodarone users

338

2.15

8.46

1.1

1.2

48.52

73.83

u/l

2.08

303

Urticaria

197

1256

1.58

8.44

1.2

74.53

64.30

u/l

0.23

177

1129

Superficial injury of hip and thigh

501

1.93

8.41

1.3

1.1

63.02

60.14

u/l

0.19

450

Disorders of lacrimal system

302

2100

1.44

8.40

1.2

58.92

61.49

u/l

0.31

269

1870

Procreative management

217

1174

1.55

8.38

1.3

1.2

74.35

65.67

u/l

0.64

200

1062

Personality disorders

165

1010

1.64

8.38

1.2

55.84

59.41

u/l

0.42

144

920

Need for other prophylactic measures

184

2.59

8.34

1.2

52.44

68.56

u/l

1.25

173

Rheumatism, unspecified

111

611

1.83

8.28

1.2

53.43

59.73

u/l

0.91

105

553

Benign neoplasm: Sigmoid colon

136

796

1.72

8.22

1.3

1.2

55.33

63.13

u/l

0.56

120

714

Problems related to lifestyle

252

2.32

8.20

1.2

1.1

67.67

63.23

u/l

0.17

228

Fissure and fistula of anal and rectal regions

152

917

1.67

8.18

1.1

1.2

52.10

64.26

u/l

2.70

144

812

Disorders of adult personality and behaviour

171

1063

1.62

8.17

1.2

58.27

60.99

u/l

0.28

148

966

Respiratory insufficiency

215

2.43

8.16

1.1

137.56

68.43

u/l

0.46

191

Other arthrosis

333

1630

1.42

8.14

1.2

56.90

67.54

u/l

2.29

310

1459

Other pulmonary heart/vessel disease

135

2.85

8.14

1.2

54.77

61.36

u/l

0.24

124

Retinal detachments and breaks

236

1580

1.50

8.11

1.2

53.75

62.43

u/l

2.27

209

1415

Other embolism and thrombosis

473

1.94

8.10

1.2

65.87

59.52

u/l

0.44

428

Other and unspecified urticaria

128

740

1.74

8.08

1.2

85.67

64.01

u/l

0.36

119

673

Alcohol-induced chronic pancreatitis

199

2.49

8.07

1.1

1.2

49.87

56.50

u/l

0.55

182

Chronic laryngitis and laryngotracheitis

106

580

1.84

8.07

1.2

1.1

52.85

60.23

u/l

1.19

513

Panic disorder

440

1.97

8.01

1.2

63.84

58.82

u/l

0.27

403

Injury of unspecified body region

237

2.34

7.96

1.3

1.2

62.88

58.27

u/l

0.15

220

Undetermined asthma

441

1.96

7.95

1.3

1.1

55.18

64.12

u/l

0.95

385

Other symptoms and signs involving cognitive functions and awareness

305

1957

1.42

7.92

1.1

1.2

62.08

60.55

u/l

0.15

268

1755

Overexertion and strenuous or repetitive movements

321

2.14

7.90

1.3

1.2

54.53

60.99

u/l

0.38

292

Ischaemic Stroke, excluding all haemorrhages

369

1992

1.38

7.87

1.2

58.87

63.24

u/l

0.60

329

1774

Poisoning by medicine

134

793

1.70

7.78

1.2

53.13

60.32

u/l

1.28

116

722

Coronary artery bypass grafting

156

707

1.65

7.78

1.2

58.91

69.05

u/l

0.90

139

635

Seborrhoeic dermatitis

297

2.17

7.77

1.4

1.1

62.24

65.48

u/l

0.15

268

Generalized anxiety disorder

466

1.92

7.76

1.2

60.07

60.78

u/l

0.04

429

Lung cancer and mesothelioma

117

568

1.77

7.73

1.2

72.41

65.18

u/l

0.39

112

492

Scar conditions and fibrosis of skin

117

2.95

7.72

1.1

1.2

60.28

53.84

u/l

0.48

108

Stomatitis and related lesions

129

758

1.71

7.70

1.2

74.76

65.66

u/l

0.38

118

688

Malignant neoplasm of urinary organs

279

2.20

7.68

1.2

1.1

77.53

56.77

u/l

0.86

249

Stroke, including SAH

417

2247

1.35

7.64

1.2

59.24

62.53

u/l

0.47

377

2005

Squamous cell neoplasms and carcinomas of the skin

205

2.41

7.56

1.2

47.98

58.28

u/l

1.19

182

Other disorders of veins

283

1979

1.43

7.56

1.2

52.82

61.62

u/l

2.09

246

1762

Other specified and unspecified personality disorders

262

2.23

7.53

1.2

61.83

59.95

u/l

0.10

243

DVT of lower extremities and pulmonary embolism

277

1935

1.43

7.51

1.2

63.79

60.59

u/l

0.33

261

1714

Acquired haemolytic anaemia

3.72

7.50

1.2

37.17

49.20

u/l

1.38

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

352

2499

1.37

7.49

1.2

62.80

61.51

u/l

0.12

327

2243

Fall on same level involving ice and snow

372

2744

1.36

7.48

1.2

62.22

62.46

u/l

0.03

333

2455

Diseases of the ear and mastoid process

755

3029

1.25

7.46

1.2

61.08

64.99

u/l

0.66

689

2714

Exposure to other and unspecified inanimate mechanical forces

213

2.37

7.45

1.2

53.82

64.72

u/l

0.90

197

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

101

560

1.81

7.39

1.2

55.14

60.38

u/l

0.61

513

Convulsions, not elsewhere classified

125

729

1.70

7.32

1.2

64.96

70.21

u/l

0.24

117

640

Dermatitis due to substances taken internally

155

2.61

7.28

1.2

66.42

57.58

u/l

0.26

143

Acute and subacute iridocyclitis

128

763

1.69

7.28

1.2

49.35

62.50

u/l

2.66

118

679

Diseases of the myoneural junction and muscle

421

1.94

7.26

1.2

1.1

62.46

67.16

u/l

0.18

378

Mental and behavioural disorders due to alcohol

298

2048

1.40

7.22

1.1

1.2

66.90

63.13

u/l

0.25

259

1849

Malignant neoplasm of bladder, including Hilmo

317

2.08

7.22

1.2

51.49

56.93

u/l

0.47

282

Other skin changes

128

765

1.68

7.22

1.2

64.31

62.02

u/l

0.15

113

677

Other specified/unspecified bacterial intestinal infections

204

2.38

7.20

1.2

1.1

50.18

60.57

u/l

0.96

188

Infections with a predominantly sexual mode of transmission

176

1136

1.55

7.18

1.2

62.28

59.12

u/l

0.29

160

1035

Behavioural syndromes associated with physiological disturbances and physical factors

590

3287

1.28

7.17

1.2

64.09

65.02

u/l

0.10

522

2962

Other diseases of upper respiratory tract

726

3029

1.25

7.15

1.3

1.2

58.41

67.25

u/l

2.06

652

2717

Impacted cerumen

341

2.04

7.15

1.1

1.2

55.44

65.41

u/l

0.99

307

Asthma/COPD (KELA code 203)

598

3226

1.27

7.15

1.2

56.83

66.56

u/l

3.10

544

2904

Other viral diseases, not elsewhere classified

109

623

1.75

7.14

1.3

1.2

72.29

77.39

u/l

0.19

102

563

Allergic conjunctivitis

365

2634

1.35

7.13

1.2

62.56

61.20

u/l

0.13

337

2372

Myocardial infarction, with ST-elevation

106

604

1.76

7.10

1.1

1.2

85.17

67.32

u/l

0.22

529

Superficial injury of lower leg

156

986

1.59

7.04

1.2

56.49

67.14

u/l

1.40

138

878

Other disorders of bone

118

695

1.71

7.03

1.2

1.1

78.06

62.33

u/l

0.75

111

629

Injuries to the wrist and hand

635

3495

1.26

7.02

1.2

62.98

65.27

u/l

0.31

561

3154

Special screening examination for other diseases and disorders

343

2.02

7.01

1.2

1.1

112.37

66.19

u/l

0.43

293

Generalized skin eruption due to drugs and medicaments

113

2.87

6.97

1.2

74.69

54.39

u/l

0.60

106

Dermatophytosis

470

1.86

6.96

1.2

68.85

64.99

u/l

0.15

420

Other disorders of the musculoskeletal system and connective tissue

102

579

1.77

6.94

1.3

1.2

61.16

61.39

u/l

0.01

525

Ventral hernia

161

1029

1.57

6.94

1.3

1.2

56.33

67.09

u/l

1.69

148

909

Fibroblastic disorders

150

944

1.60

6.90

1.2

57.91

64.19

u/l

0.63

130

839

Rash and other nonspecific skin eruption

346

2.01

6.89

1.3

1.2

72.24

66.31

u/l

0.17

313

Other neurological diseases

469

2834

1.30

6.88

1.2

58.85

62.63

u/l

0.64

430

2522

Polyuria

137

845

1.63

6.85

1.3

1.2

53.58

66.31

u/l

2.24

120

750

Traumatic subdural haemorrhage

425

1.89

6.85

1.2

58.42

69.85

u/l

0.73

378

Crystal arthropathies, rheuma endpoint

4.17

6.85

1.1

1.0

58.00

60.23

u/l

0.08

Iridocyclitis

147

923

1.60

6.84

1.2

51.11

66.21

u/l

2.74

137

816

Non-allergic asthma (mode)

115

672

1.70

6.80

1.2

51.97

67.08

u/l

2.80

103

591

Poisoning by drugs, medicaments and biological substances

143

895

1.60

6.74

1.2

52.31

60.04

u/l

1.57

125

811

Glucagon-like peptide-1 (GLP-1) analogues

190

1268

1.51

6.73

1.2

51.50

61.59

u/l

2.49

175

1133

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

190

1268

1.51

6.73

1.2

51.50

61.59

u/l

2.49

175

1133

Unspecified acute lower respiratory infection

476

1.84

6.69

1.2

59.08

64.86

u/l

0.29

422

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

296

2.08

6.67

1.1

47.80

72.50

u/l

1.87

268

Fracture of skull and facial bones

125

759

1.65

6.66

1.2

84.47

61.51

u/l

1.02

110

687

Other crystal arthropathies

4.08

6.65

1.1

58.00

58.09

u/l

0.00

Specific personality disorders

135

836

1.62

6.65

1.2

59.04

58.90

u/l

0.01

113

759

Other viral diseases

211

1430

1.47

6.65

1.2

67.56

68.88

u/l

0.08

196

1285

Diffuse large B-cell lymphoma, including Hilmo

122

2.74

6.62

1.2

1.1

70.00

52.02

u/l

0.54

109

Diffuse large B-cell lymphoma

122

2.74

6.62

1.2

1.1

70.00

52.02

u/l

0.54

109

Diffuse large B-cell lymphoma, helper endpoint

122

2.74

6.62

1.2

1.1

70.00

52.02

u/l

0.54

109

Mental and behavioural disorders due to alcohol, excluding acute intoxication

257

1814

1.41

6.61

1.2

66.18

63.50

u/l

0.15

220

1625

Soft tissue disorders related to use, overuse and pressure

177

1170

1.52

6.57

1.2

55.24

62.96

u/l

1.21

159

1038

COPD-related respiratory insufficiency

415

1.89

6.57

1.1

1.2

58.19

64.16

u/l

0.31

370

Chronic sinusitis

273

1958

1.40

6.56

1.3

1.2

52.10

64.30

u/l

5.57

251

1740

Anterior Iridocyclitis

132

817

1.62

6.54

1.2

49.57

62.52

u/l

2.70

122

730

Status post-ami

157

765

1.57

6.51

1.1

1.2

57.24

67.95

u/l

1.09

146

687

Other complications of surgical and medical care, not elsewhere classified

320

2.02

6.46

1.2

1.1

52.37

75.11

u/l

1.49

285

Otitis externa

139

874

1.60

6.46

1.3

1.2

66.94

63.48

u/l

0.18

126

780

Symptoms and signs involving speech and voice

221

1534

1.45

6.44

1.2

57.05

62.71

u/l

0.76

200

1364

Other and unspecified drugs and medicaments

274

2.10

6.40

1.1

1.2

47.65

67.98

u/l

1.35

253

Unspecified urinary incontinence

349

1.97

6.39

1.1

56.97

60.89

u/l

0.37

318

Benign neoplasm: Rectum, anus and anal canal

134

838

1.61

6.38

1.2

59.77

64.34

u/l

0.23

119

742

Obsessive-compulsive disorder

142

2.55

6.35

1.2

46.09

60.41

u/l

1.67

132

Bipolar affective disorders

109

648

1.69

6.32

1.2

52.70

57.00

u/l

0.55

587

Pure hyperglyceridaemia

3.50

6.32

1.2

56.08

50.62

u/l

0.35

Internal derangement of knee

214

1475

1.45

6.30

1.2

55.26

66.27

u/l

2.49

200

1317

Atopic dermatitis

337

2056

1.35

6.29

1.2

61.22

68.31

u/l

1.00

310

1856

Neuromuscular dysfunction of bladder

283

2.07

6.27

1.4

1.1

58.21

65.38

u/l

0.38

258

Social phobias

199

2.27

6.20

1.2

50.32

61.16

u/l

1.15

185

Nonischemic cardiomyopathy

311

2.01

6.20

1.0

1.2

126.00

69.09

u/l

0.64

275

Other/unspecified synovitis and tenosynovitis

417

1.86

6.16

1.2

60.00

61.19

u/l

0.07

381

Viral warts

127

791

1.61

6.16

1.2

63.69

66.14

u/l

0.11

119

715

Malignant neoplasm of colon, including Hilmo

107

638

1.68

6.13

1.1

1.2

73.05

57.64

u/l

0.91

563

Visual disturbances and blindness

327

2443

1.34

6.13

1.2

66.46

63.22

u/l

0.11

297

2181

Early onset COPD

146

941

1.56

6.13

1.1

1.2

57.94

64.76

u/l

0.54

130

837

therapeutic use

2.87

6.13

1.4

1.2

56.50

53.44

u/l

0.15

Benign neoplasm: Adrenal gland

286

2.05

6.12

1.2

50.19

59.84

u/l

1.05

260

Caries of enamel

551

3165

1.26

6.10

1.2

70.17

62.83

u/l

0.66

500

2846

Malignant neoplasm of thyroid gland

201

2.26

6.08

1.1

85.02

56.40

u/l

0.90

182

Deforming dorsopathies

184

1248

1.48

6.07

1.3

1.2

59.95

64.39

u/l

0.55

168

1110

Malignant melanoma of skin, including Hilmo

477

1.79

6.07

1.2

56.50

56.20

u/l

0.01

419

Sequelae of cerebrovascular disease

222

1341

1.43

6.06

1.1

1.2

60.13

61.81

u/l

0.15

201

1190

Transport accidents

260

1610

1.39

6.05

1.2

60.47

64.91

u/l

0.46

226

1470

Follow-up examination after treatment for malignant neoplasms

377

1.90

6.05

1.2

1.1

58.25

60.78

u/l

0.13

323

Bacterial, viral and other infectious agents

247

2.12

6.04

1.2

64.61

70.80

u/l

0.18

230

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

150

964

1.54

6.03

1.1

1.2

90.69

63.37

u/l

0.85

134

876

Polyarthrosis

141

839

1.57

6.01

1.2

52.95

63.40

u/l

1.98

127

748

Barrett oesophagus

129

2.59

5.97

1.1

1.2

41.26

66.81

u/l

1.91

118

Benign neoplasm of other and unspecified endocrine glands

510

1.76

5.94

1.2

49.69

59.21

u/l

1.67

466

Suicide or other Intentional self-harm

146

948

1.55

5.94

1.2

56.07

60.98

u/l

0.53

129

856

Retinal detachment with retinal break

474

1.78

5.90

1.2

50.82

65.16

u/l

2.34

428

Other and unspecified nail disorders

3.25

5.90

1.2

79.91

56.13

u/l

1.09

Thyrotoxicosis with toxic multinodular goitre

224

2.17

5.86

1.2

72.27

56.17

u/l

0.91

204

Melanocytic naevi

185

1266

1.47

5.85

1.3

1.2

65.19

61.55

u/l

0.21

164

1138

Benign neoplasm: Rectum

119

740

1.62

5.84

1.2

59.09

65.04

u/l

0.28

106

664

COPD, hospital admissions 3, with asthma pneumonia sepsis

162

918

1.51

5.84

1.2

59.53

64.41

u/l

0.35

146

818

Other headache syndromes

264

1923

1.38

5.83

1.2

57.32

61.46

u/l

0.51

237

1720

Haemolytic anaemias

102

2.78

5.81

1.2

44.32

50.56

u/l

0.51

Other diseases of lip and oral mucosa

260

1893

1.38

5.81

1.2

56.76

63.62

u/l

1.20

223

1698

Monoamine oxidase A inhibitors

462

1.79

5.80

1.2

55.89

63.04

u/l

0.53

417

Mental and behavioural disorders due to opioids

2.89

5.79

1.3

1.2

60.62

53.69

u/l

0.35

Use of pramipexole

150

988

1.53

5.74

1.2

60.91

63.22

u/l

0.22

129

876

Sleep disorders

555

3220

1.25

5.74

1.2

64.38

63.56

u/l

0.09

490

2899

Other symptoms and signs involving the digestive system and abdomen

108

660

1.64

5.69

1.2

74.25

63.71

u/l

0.66

100

594

Aortic aneurysm

126

784

1.58

5.68

1.2

49.24

64.64

u/l

2.97

115

695

Malignant neoplasm of thyroid gland, including Hilmo

247

2.08

5.67

1.1

81.48

55.32

u/l

0.96

221

Somatoform disorder

103

623

1.66

5.65

1.2

57.31

57.68

u/l

0.03

568

Hypoplasia of dental enamel , including avohilmo

3.45

5.60

1.6

1.1

263.16

196.05

u/l

0.15

Other problems related to primary support group, including family circumstances

314

1.93

5.60

1.1

1.2

128.63

70.64

u/l

0.74

290

Thiazolidinediones

409

1.82

5.60

1.1

1.2

54.95

64.93

u/l

1.06

370

Bacterial, viral and other infectious agents

276

2.01

5.55

1.2

63.88

73.72

u/l

0.34

255

Retinal vascular disorders

425

1.80

5.53

1.2

59.09

65.77

u/l

0.55

385

Trochanteric bursitis

589

1.67

5.53

1.2

47.81

60.27

u/l

2.51

534

Alcohol use disorder, ICD-based

233

1681

1.39

5.52

1.2

68.72

63.58

u/l

0.28

198

1505

COPD

277

1673

1.36

5.52

1.2

55.83

64.23

u/l

1.18

247

1483

Molar incisor enamel hypoplasia

3.30

5.51

1.6

1.1

280.10

186.21

u/l

0.23

severe traumatic brain injury, does not include concussion

128

822

1.56

5.50

1.2

65.53

65.64

u/l

0.00

112

730

Other secondary coxarthrosis

117

2.60

5.49

1.1

1.2

55.04

54.98

u/l

0.00

110

Acanthosis nigricans

16.93

5.48

1.1

1.0

51.25

43.60

u/l

—

Other inflammation of eyelid

546

1.70

5.45

1.3

1.2

106.77

62.98

u/l

0.53

493

Diseases of salivary glands

204

1443

1.42

5.44

1.2

59.79

61.63

u/l

0.19

188

1291

Personal history of other diseases and conditions

270

2.00

5.43

1.2

1.1

63.66

73.37

u/l

0.50

246

Idiopathic thrombocytopenic purpura

2.85

5.43

1.4

1.1

53.96

85.78

u/l

0.58

Disorders of breast

328

2266

1.32

5.42

1.2

56.90

58.68

u/l

0.39

299

2043

Injuries to the shoulder and upper arm

527

3422

1.24

5.39

1.2

59.53

64.80

u/l

1.13

476

3068

Pneumonia derived septicemia

2.77

5.38

1.4

1.2

103.81

59.51

u/l

0.58

Corneal scars and opacities

2.90

5.38

1.1

1.2

59.58

52.29

u/l

0.39

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

164

1116

1.47

5.37

1.2

54.66

60.67

u/l

0.80

145

1014

Other specified disorders of kidney and ureter

107

2.65

5.34

1.1

1.2

94.32

52.86

u/l

1.23

101

Retinal vascular occlusion

423

1.78

5.32

1.2

59.48

65.84

u/l

0.51

383

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

104

642

1.63

5.30

1.2

72.53

56.80

u/l

1.25

560

Malignant neoplasm of colon

490

1.72

5.30

1.1

79.84

56.80

u/l

1.17

429

Phlebitis and thrombophlebitis (not including DVT)

145

967

1.51

5.27

1.2

58.23

63.51

u/l

0.49

131

861

Ingrowing nail

156

2.33

5.27

1.2

1.1

79.94

57.87

u/l

0.36

144

Atopic dermatitis, strict definition with reimbursement

158

1034

1.48

5.26

1.2

66.13

69.90

u/l

0.19

141

935

Other viral hepatitis

175

2.25

5.26

1.3

1.2

62.88

57.90

u/l

0.30

162

Malignant neoplasm of respiratory system and intrathoracic organs

112

583

1.61

5.26

1.1

1.2

76.10

57.03

u/l

1.53

107

514

Infections with a predominantly sexual mode of transmission

210

1397

1.40

5.25

1.2

60.23

60.39

u/l

0.01

187

1276

Carcinoma in situ of skin

283

1.96

5.21

1.1

1.2

52.33

64.67

u/l

0.92

252

Viral hepatitis

215

2.11

5.20

1.3

1.2

62.67

61.71

u/l

0.04

200

Acute suppurative otitis media

121

725

1.56

5.17

1.3

1.2

78.41

71.24

u/l

0.31

114

663

Disturbances of skin sensation

166

1142

1.46

5.17

1.3

1.2

51.33

59.65

u/l

1.53

154

1019

Restless leg syndrome

517

1.69

5.15

1.1

1.2

56.49

64.21

u/l

0.78

474

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

431

1.72

5.13

1.3

1.2

115.57

74.31

u/l

0.68

394

Hyperaldosteronism

2.76

5.13

1.2

49.48

49.59

u/l

0.01

Malignant neoplasm of bronchus and lung, including Hilmo

115

610

1.58

5.13

1.2

73.02

57.10

u/l

1.21

110

536

Enthesopathies of lower limb, excluding foot

143

957

1.50

5.12

1.3

1.2

56.65

62.51

u/l

0.53

124

854

Carpal tunnel syndrome

397

2755

1.27

5.07

1.2

58.18

60.10

u/l

0.37

364

2459

Delivery, wide proxy

113

932

0.64

5.04

1.3

1.2

62.35

59.90

u/l

0.23

103

833

COPD, hospital admission 2, with asthma infections

191

1158

1.42

5.03

1.2

58.80

63.73

u/l

0.43

172

1025

Acute pharyngitis

405

1.77

5.02

1.3

1.2

121.68

69.86

u/l

0.49

365

Inflammatory diseases of the central nervous system

266

1.97

5.01

1.2

56.09

63.80

u/l

0.53

243

Recurrent aphthous stomatitis , including avohilmo

521

1.68

5.01

1.2

84.57

67.55

u/l

0.54

473

Superficial injury of abdomen, lower back and pelvis

491

1.70

5.00

1.3

1.2

100.38

66.51

u/l

0.35

436

Unspecific neurodegenerative disorder

138

1397

0.67

5.00

1.1

1.2

62.20

61.48

u/l

0.04

112

1250

Postprocedural musculoskeletal disorders, not elsewhere classified

253

1.99

4.98

1.2

64.73

58.45

u/l

0.31

231

Sulfonylureas

213

1222

1.39

4.98

1.2

55.38

65.76

u/l

1.64

198

1087

Other chronic obstructive pulmonary disease

265

1631

1.34

4.97

1.2

56.18

64.38

u/l

1.08

236

1450

Ankylosing spondylitis, strict definition

123

2.46

4.97

1.1

1.2

49.03

56.31

u/l

0.68

114

Drug-induced adrenocortical insufficiency

3.18

4.95

1.2

72.26

94.96

u/l

0.21

Lumbar disc prolapse

382

2298

1.28

4.95

1.2

55.84

63.26

u/l

2.13

338

2063

Other chronic obstructive pulmonary disease, including avohilmo

330

2104

1.30

4.92

1.1

1.2

55.10

63.10

u/l

1.40

293

1877

COPD related to multimorbidity

236

1466

1.36

4.91

1.1

1.2

52.79

62.88

u/l

2.17

211

1298

Disease of hard tissues of teeth, NOS

327

1305

1.31

4.91

1.2

58.62

60.22

u/l

0.16

292

1168

Allergic asthma (mode), excluding more controls

115

725

1.56

4.90

1.2

62.98

66.22

u/l

0.24

106

645

Colorectal cancer

124

796

1.53

4.87

1.1

1.2

85.75

57.08

u/l

1.35

114

700

Injury, poisoning and certain other consequences of external causes

320

1220

1.32

4.86

1.2

69.61

69.32

u/l

0.01

289

1115

Dermatophytosis

358

2802

1.28

4.85

1.2

67.00

64.29

u/l

0.15

326

2503

Conjunctivitis (acute, non atopic)

161

1112

1.45

4.84

1.2

57.74

65.35

u/l

0.97

150

992

Insomnia

533

3171

1.23

4.81

1.2

63.83

63.19

u/l

0.06

467

2853

Fracture at wrist and hand level

192

1373

1.40

4.80

1.2

62.88

63.46

u/l

0.04

164

1233

Colon adenocarcinoma

356

1.81

4.79

1.1

80.64

58.43

u/l

0.93

315

Other and unspecified disorders of vitreous body

280

2099

1.32

4.79

1.2

59.29

62.41

u/l

0.36

250

1866

Other congenital malformations

400

1.76

4.78

1.2

57.41

75.69

u/l

1.13

370

Fracture of foot, except ankle

139

940

1.48

4.76

1.4

1.2

58.43

62.76

u/l

0.46

122

849

Abscess of anal and rectal regions

245

1.97

4.68

1.1

62.02

60.76

u/l

0.06

221

Corneal ulcer

108

695

1.56

4.68

1.4

1.2

61.13

62.68

u/l

0.11

101

623

Other congenital malformations

245

1.97

4.67

1.2

62.38

84.51

u/l

0.84

225

Primary gonarthrosis, bilateral

343

2297

1.28

4.66

1.2

56.11

61.58

u/l

1.55

301

2052

Fall on and from stairs and steps

157

1094

1.44

4.62

1.2

56.15

67.01

u/l

1.65

142

971

Hallux rigidus

573

1.61

4.59

1.1

1.2

54.82

63.56

u/l

1.16

502

Single spontaneous delivery

154

1169

0.70

4.59

1.2

59.82

60.02

u/l

0.02

141

1051

Use of anticholinesterases

103

1248

0.65

4.58

1.1

1.2

68.19

61.13

u/l

0.42

1110

N06DA Anticholinesterases

103

1248

0.65

4.58

1.1

1.2

68.19

61.13

u/l

0.42

1110

Gonarthrosis,primary

582

2963

1.21

4.57

1.2

59.15

61.72

u/l

0.41

520

2662

Psoriasis (vulgaris), strict definition

2.58

4.56

1.2

50.64

53.69

u/l

0.21

Unstable angina pectoris

213

1230

1.37

4.56

1.2

56.10

64.47

u/l

1.32

191

1085

Car occupant injured in other and unspecified transport accidents

102

652

1.57

4.55

1.2

58.63

62.55

u/l

0.30

598

Umbilical hernia

148

1023

1.45

4.55

1.2

61.62

63.44

u/l

0.07

137

908

Erosion of teeth , including avohilmo

135

917

1.48

4.54

1.2

72.04

63.04

u/l

0.54

118

832

Dilated cardiomyopathy

407

1.73

4.54

1.1

1.2

97.08

65.73

u/l

0.36

365

255

1766

1.33

4.54

1.2

57.91

61.26

u/l

0.36

228

1563

Colonic or urogenital fistula

165

1165

1.42

4.53

1.1

1.2

51.79

63.16

u/l

2.90

157

1031

Superficial injury of head

134

910

1.48

4.51

1.1

1.2

61.44

64.57

u/l

0.25

117

813

Benign neoplasm: Ascending colon

545

1.62

4.50

1.2

53.31

63.92

u/l

1.57

489

Visual disturbances

294

2271

1.30

4.50

1.2

66.40

62.98

u/l

0.10

264

2028

Open wound of wrist and hand

239

1752

1.34

4.50

1.2

64.87

64.98

u/l

0.01

209

1580

Thoracic aortic aneurysm

476

1.67

4.50

1.2

50.54

66.16

u/l

1.78

423

Fenamates

411

1.61

4.49

1.1

1.2

49.28

63.74

u/l

2.52

373

Spirochaetal infections, other/unspecified

313

1.83

4.49

1.2

51.37

61.18

u/l

1.32

289

Superficial injury of wrist and hand

111

726

1.53

4.48

1.2

59.21

68.12

u/l

0.62

103

662

Other symptoms and signs involving the nervous and musculoskeletal systems

250

1890

1.33

4.47

1.2

63.62

63.99

u/l

0.03

230

1688

Mental and behavioural disorders due to sedatives or hypnotics

208

2.03

4.47

1.1

1.2

65.30

57.47

u/l

0.38

194

Granulomatous disorders of skin and subcutaneous tissue

2.80

4.47

1.4

1.1

52.90

50.89

u/l

0.12

Emotionally unstable personality disorder

357

1.77

4.46

1.2

60.33

62.27

u/l

0.09

331

Haemorrhoids and perianal venous thrombosis

183

1316

1.39

4.46

1.2

56.94

63.10

u/l

1.13

165

1172

Other enthesopathies

182

1313

1.39

4.42

1.2

61.47

61.69

u/l

0.02

163

1171

Palmar fascial fibromatosis [Dupuytren]

541

1.62

4.38

1.3

1.2

56.52

67.98

u/l

0.87

473

Excessive attrition of teeth

321

2517

1.28

4.38

1.2

62.05

62.39

u/l

0.04

287

2261

Hemiplegia

150

2.22

4.37

1.2

53.77

56.50

u/l

0.11

139

Acute nephritic syndrome

2.92

4.35

1.1

49.43

59.64

u/l

0.43

Artrosis, including avohilmo

515

2310

1.22

4.34

1.2

60.34

63.95

u/l

0.46

456

2088

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

629

1.56

4.33

1.2

53.99

60.64

u/l

0.94

574

Non-Hodgkin lymphoma, all

2.55

4.30

1.3

1.2

68.83

53.56

u/l

0.84

Paracetamol or NSAID medication

238

1.70

4.30

1.1

1.2

57.60

97.56

u/l

1.48

215

Myocardial infarction, unclassifiable

121

725

1.49

4.27

1.2

85.26

65.59

u/l

0.30

110

646

Later onset COPD, excluding more controls

112

569

1.53

4.27

1.2

53.09

70.24

u/l

1.35

100

491

Dental pulpitis, including avohilmo

541

2906

1.21

4.26

1.2

64.83

63.21

u/l

0.16

475

2633

Angina pectoris

342

1796

1.27

4.26

1.2

58.72

61.35

u/l

0.40

311

1597

Infective dermatitis

372

1.73

4.18

1.1

1.2

71.31

61.77

u/l

0.24

336

Hypertrophic cardiomyopathy

128

2.29

4.14

1.3

1.2

44.88

57.16

u/l

0.95

120

Malignant neoplasm of small intestine, including Hilmo

2.82

4.13

1.2

54.63

50.74

u/l

0.25

Alcohol dependence

142

995

1.43

4.11

1.1

1.2

75.08

64.42

u/l

0.40

119

887

179

1134

1.38

4.10

1.2

62.35

61.12

u/l

0.09

155

1013

Striking against or struck by other objects

170

1229

1.39

4.09

1.2

75.95

67.52

u/l

0.16

157

1104

Delivery

159

1170

0.71

4.08

1.2

58.02

60.03

u/l

0.24

144

1052

Other and unspecified myopathies

280

1.83

4.05

1.2

1.1

68.43

73.33

u/l

0.12

252

Other and unspecified follicular disorders

123

2.30

4.04

1.1

1.2

65.95

53.59

u/l

0.64

116

Special screening examination for infectious and parasitic diseases

104

501

1.53

4.04

1.2

1.1

72.14

71.06

u/l

0.03

446

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

4.25

4.03

1.1

73.00

45.30

u/l

1.13

Voice disturbances

169

1229

1.38

3.97

1.2

59.71

61.81

u/l

0.17

151

1094

COPD, hospital admissions

264

1727

1.30

3.96

1.2

56.15

63.81

u/l

1.00

236

1536

Suppurative and unspecified otitis media

173

1116

1.38

3.96

1.3

1.2

74.85

67.78

u/l

0.46

163

1007

COPD, early/later onset

266

1741

1.29

3.89

1.2

56.15

63.70

u/l

0.99

237

1550

Pain in thoracic spine

622

1.53

3.88

1.1

1.2

95.42

63.13

u/l

0.40

553

Allergic asthma (mode)

115

766

1.47

3.88

1.2

62.98

65.44

u/l

0.18

106

679

Other viral diseases, not elsewhere classified

138

968

1.42

3.87

1.3

1.2

67.21

69.99

u/l

0.13

127

872

Spontaneous rupture of synovium and tendon

292

1.79

3.86

1.1

1.2

61.41

58.56

u/l

0.16

271

Benign neoplasm of eye and adnexa

374

1.69

3.85

1.1

1.2

64.41

67.32

u/l

0.12

346

Other blood glucose lowering drugs, excl. Insulins

100

664

1.51

3.84

1.1

1.2

54.78

62.89

u/l

1.10

590

Ganglion

125

868

1.45

3.83

1.1

1.2

60.59

61.56

u/l

0.07

115

778

Actinic keratosis

231

1637

1.31

3.82

1.2

56.00

61.35

u/l

0.89

205

1449

Rotator cuff syndrome

360

2079

1.24

3.82

1.2

57.62

64.23

u/l

1.20

325

1853

Orthopaedic devices associated with adverse incidents

2.88

3.82

1.4

1.1

53.94

50.01

u/l

0.16

Inflammatory diseases of female pelvic organs

384

2290

1.24

3.81

1.2

58.69

58.77

u/l

0.01

339

2077

Macular hole

208

1.94

3.78

1.2

46.85

56.43

u/l

1.49

191

Cerebral cysts

160

2.08

3.77

1.2

73.06

64.25

u/l

0.28

150

Melanocytic naevi of trunk

392

1.67

3.75

1.2

1.1

75.89

61.78

u/l

0.33

358

Injury of eye and orbit

454

1.61

3.73

1.2

61.20

63.55

u/l

0.12

412

Other diseases of peritoneum

141

2.15

3.72

1.1

1.2

57.87

54.68

u/l

0.16

130

Other extrapyramidal and movement disorders in other diseases

145

1041

1.40

3.71

1.2

56.23

63.88

u/l

1.24

128

921

Follicular cysts of skin and subcutaneous tissue

104

703

1.49

3.68

1.2

67.81

61.89

u/l

0.26

627

Appendectomy

378

2953

1.23

3.64

1.2

55.58

63.61

u/l

2.20

342

2653

Organ-limited amyloidosis

8.04

3.59

1.1

1.0

46.43

35.67

u/l

—

Skin changes due to chronic exposure to nonionizing radiation

236

1687

1.29

3.58

1.2

58.82

61.46

u/l

0.25

210

1496

Dermatographic urticaria

205

1.92

3.58

1.3

1.1

63.76

63.71

u/l

0.00

190

Gonarthrosis, primary, with knee surgery

372

2416

1.23

3.58

1.2

54.81

62.48

u/l

2.20

331

2157

Localized swelling, mass and lump of skin and subcutaneous tissue

188

1415

1.33

3.57

1.2

58.32

64.89

u/l

0.56

176

1249

D07AA Corticosteroids, weak (group I)

506

1.56

3.57

1.2

80.53

72.12

u/l

0.17

461

Adhesive capsulitis of shoulder

104

708

1.48

3.57

1.2

50.54

63.73

u/l

3.09

626

Speech therapy

162

1193

1.36

3.56

1.2

63.54

63.17

u/l

0.02

142

1059

Osteogenesis imperfecta

10.62

3.55

1.0

93.17

198.50

u/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

156

1144

1.37

3.52

1.2

67.78

63.38

u/l

0.34

141

1039

Rheumatic fever with heart involvement

10.29

3.52

1.2

1.3

44.00

51.33

u/l

—

Allergic urticaria

264

1.79

3.51

1.2

1.1

42.60

76.72

u/l

2.57

242

Vulvovaginal ulceration/inflammation in other diseases

165

2.01

3.49

1.1

1.2

53.30

65.80

u/l

0.89

153

Other congenital malformations of skin

125

2.18

3.49

1.1

1.2

57.00

60.42

u/l

0.12

119

Other congenital malformations of skin

265

1.78

3.47

1.1

1.2

52.60

73.92

u/l

1.12

246

Superficial injury of ankle and foot

378

1.65

3.46

1.3

1.1

64.76

78.91

u/l

0.73

347

Other/unspecified enthesopathies of lower limb, excluding foot

237

1.83

3.43

1.2

64.05

66.54

u/l

0.06

216

Colorectal adenocarcinoma

655

1.48

3.43

1.1

1.2

90.75

57.22

u/l

1.26

578

Malignant neoplasm of oral cavity, including Hilmo

113

2.23

3.42

1.4

1.1

52.60

51.21

u/l

0.06

100

Superficial injury of thorax

513

1.55

3.40

1.2

65.37

59.56

u/l

0.39

460

Subjective visual disturbances

149

1092

1.37

3.40

1.2

51.16

63.53

u/l

2.79

136

975

Other enthesopathy of foot (+metatarsalgia)

389

1.63

3.36

1.3

1.2

64.57

59.23

u/l

0.24

356

Other disorders of breast

555

1.52

3.36

1.2

55.18

60.54

u/l

0.71

507

Other disorders of conjunctiva

555

1.52

3.35

1.2

52.11

63.52

u/l

1.32

496

Metatarsalgia

351

1.66

3.35

1.3

1.2

65.70

59.18

u/l

0.28

326

Seborrhoeic keratosis

131

943

1.39

3.34

1.3

1.2

69.16

64.50

u/l

0.22

111

828

Carcinoma in situ of breast, intraductal

406

1.61

3.33

1.2

60.83

58.90

u/l

0.12

373

Aggressive periodontitis

2.57

3.31

1.3

1.2

60.67

51.72

u/l

0.41

Alzheimer disease, including avohilmo

120

1181

0.71

3.31

1.1

1.2

61.33

61.75

u/l

0.02

100

1051

Heartburn

360

1.65

3.30

1.2

57.62

66.99

u/l

0.72

326

Other disorders of bladder

391

1.62

3.30

1.2

54.96

70.70

u/l

1.08

346

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

115

2.19

3.29

1.2

59.32

53.92

u/l

0.22

104

Polycystic ovarian syndrome, consortium definition

448

2216

1.20

3.28

1.2

58.99

58.87

u/l

0.02

416

1990

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

297

2328

1.24

3.28

1.2

56.79

64.89

u/l

2.39

266

2076

Pain associated with micturition

424

1.59

3.25

1.2

55.28

71.33

u/l

1.16

381

Alzheimer disease

1016

0.69

3.25

1.1

1.2

61.74

61.78

u/l

0.00

910

Pregnancy, childbirth and the puerperium

104

779

0.70

3.24

1.3

1.2

61.98

60.99

u/l

0.06

694

Alcohol-induced acute pancreatitis

103

2.25

3.23

1.0

1.2

54.89

62.72

u/l

0.25

Necrosis of pulp, including avohilmo

324

2638

1.23

3.22

1.2

61.87

63.08

u/l

0.09

296

2369

Memory loss

318

1.68

3.18

1.2

62.51

60.79

u/l

0.05

287

Other diseases of gallbladder

137

2.06

3.17

1.2

57.39

53.86

u/l

0.15

125

Maternal care for other conditions predominantly related to pregnancy

111

769

1.42

3.16

1.2

53.82

59.77

u/l

0.87

103

703

Chondropathies

539

1.51

3.15

1.2

70.04

57.31

u/l

0.83

490

Other bursopathies

507

1.53

3.15

1.4

1.2

56.59

62.92

u/l

0.72

448

Post-traumatic wound infection, not elsewhere classified

2.49

3.14

1.1

1.2

42.83

56.66

u/l

0.89

Open wound of forearm

267

1.73

3.11

1.2

1.1

78.13

64.37

u/l

0.42

241

Plantar fascial fibromatosis

382

1.61

3.11

1.2

54.39

59.03

u/l

0.41

353

Other disorders of eye and adnexa

525

1.51

3.10

1.3

1.1

56.10

66.90

u/l

0.91

481

Disorders of tooth development and eruption

423

1.52

3.07

1.3

1.2

53.45

62.68

u/l

1.21

387

Other surgical follow-up care

2.39

3.06

1.3

1.2

63.74

54.80

u/l

0.22

Otitis media, unspecified

274

1.69

3.06

1.3

1.2

137.13

73.31

u/l

0.41

255

Diplopia

457

1.54

2.99

1.3

1.2

53.73

63.19

u/l

0.92

416

Other hammer toe(s) (acquired)

107

700

1.42

2.99

1.1

1.2

53.74

61.43

u/l

0.87

619

Transient ischemic attack

308

2040

1.22

2.96

1.2

57.70

63.20

u/l

0.83

277

1822

Pneumococcal septicemia

101

2.20

2.94

1.4

1.2

91.09

56.33

u/l

0.40

Malignant neoplasm of small intestine

2.86

2.93

1.2

60.00

49.84

u/l

0.81

Sequelae of injuries, of poisoning and of other consequences of external causes

128

941

1.36

2.92

1.2

60.62

62.33

u/l

0.13

110

846

Anogenital herpesviral [herpes simplex] infection

156

1.93

2.89

1.1

1.2

63.88

60.82

u/l

0.09

145

Use of memantine

936

0.68

2.89

1.0

1.2

55.02

62.20

u/l

0.90

832

Use of other anti-dementia drugs

936

0.68

2.89

1.0

1.2

55.02

62.20

u/l

0.90

832

Wet age-related macular degeneration

653

1.43

2.88

1.2

67.65

64.68

u/l

0.15

577

Oligomenorrhoea

2.26

2.87

1.3

1.2

51.90

58.90

u/l

0.70

Ovarian cyst

221

1003

1.27

2.87

1.2

54.81

58.61

u/l

0.53

200

903

Oxicams

134

558

1.37

2.86

1.1

1.2

67.88

63.15

u/l

0.25

121

509

Supplementary factors related to causes of morbidity and mortality classified elsewhere

170

1308

1.30

2.85

1.2

72.79

63.73

u/l

1.04

152

1163

Cervicocranial syndrome

415

1.55

2.84

1.3

1.2

58.91

63.39

u/l

0.33

370

Intracerebral haemorrhage

431

1.54

2.83

1.3

1.2

63.25

63.30

u/l

0.00

386

117

801

1.38

2.82

1.2

60.73

62.61

u/l

0.11

100

714

Complications of the puerperium, not elsewhere classified

103

2.15

2.81

1.4

1.1

49.78

73.30

u/l

1.21

Alcohol abuse, main dg, excluding more controls

456

1.52

2.81

1.1

1.2

60.38

62.04

u/l

0.11

411

Other or unspecified common variable immunodeficiency

8.62

2.77

1.6

1.3

48.40

54.83

u/l

—

Atopic dermatitis, strict definition

143

1058

1.33

2.74

1.2

67.62

69.11

u/l

0.07

129

970

Other and unspecified glaucoma

248

1.70

2.72

1.2

67.81

62.54

u/l

0.18

221

Malignant neoplasm of head and neck

218

1.75

2.71

1.2

1.1

77.26

54.89

u/l

0.65

195

Respiratory conditions due to other external agents

2.53

2.71

1.5

1.2

41.33

51.12

u/l

0.99

Radiculopathy

674

1.41

2.71

1.1

1.2

54.18

66.33

u/l

1.52

589

Assault

388

1.55

2.71

1.3

1.2

66.07

63.19

u/l

0.13

352

Oter anti-inflammatory and antirheumatic agents, non-steroids

128

519

1.36

2.70

1.2

59.98

62.75

u/l

0.18

117

471

COPD, hospital admissions 1, only main diagnosis

190

1277

1.28

2.70

1.2

58.57

63.99

u/l

0.49

168

1131

Cervicalgia

121

897

1.35

2.66

1.2

56.21

62.63

u/l

0.79

108

791

Car occupant injured in noncollision transport accident

106

2.09

2.63

1.2

65.12

51.98

u/l

0.56

Diseases of middle ear and mastoid

292

1971

1.21

2.63

1.2

67.35

66.80

u/l

0.04

273

1758

Nummular dermatitis

251

1.68

2.62

1.5

1.1

74.69

68.60

u/l

0.12

226

Epilepsy

164

1269

1.29

2.61

1.2

64.81

71.15

u/l

0.40

150

1132

Leisure time condition

671

1.41

2.60

1.2

75.90

64.80

u/l

0.78

606

Anogenital herpesviral [herpes simplex] infection

298

1.62

2.58

1.1

1.2

56.55

59.50

u/l

0.14

278

Other noninflammatory disorders of vulva and perineum

385

1.54

2.58

1.2

49.19

57.33

u/l

0.98

348

Acute and transient psychotic disorders

401

1.53

2.58

1.1

1.2

71.25

61.19

u/l

0.41

366

Hyperplasia of prostate

173

761

1.29

2.57

1.2

65.33

66.39

u/l

0.04

149

678

Unspecified lump in breast

100

724

1.39

2.56

1.2

58.95

60.20

u/l

0.11

650

Polyp of the female genital tract

205

934

1.26

2.55

1.2

61.04

57.56

u/l

0.60

186

837

Benign paroxysmal vertigo

177

1393

1.27

2.54

1.2

58.89

61.80

u/l

0.35

158

1244

Disorders of eyelid in diseases classified elsewhere

108

2.05

2.52

1.0

1.3

70.77

52.98

u/l

0.75

100

Other epidermal thickening

122

1.98

2.51

1.4

1.2

53.79

52.10

u/l

0.11

116

Degenerative diseases of the nervous system

120

1172

0.75

2.50

1.1

1.2

65.90

61.39

u/l

0.27

1045

Impaction of intestines

4.46

2.49

1.1

1.0

48.43

61.31

u/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

337

2244

1.19

2.49

1.2

66.67

60.23

u/l

0.71

300

2030

Meniscus derangement

298

1670

1.20

2.43

1.2

58.03

67.14

u/l

1.61

270

1496

Spondylolisthesis/Spondylolysis

111

825

1.35

2.43

1.3

1.2

54.34

63.25

u/l

1.30

101

728

Sequelae of injuries of lower limb

327

1.57

2.43

1.2

55.76

59.25

u/l

0.23

299

Alzheimer’s disease (Late onset)

777

0.68

2.42

1.1

1.2

53.22

60.25

u/l

0.62

692

Nonsuppurative otitis media

602

1.38

2.41

1.2

100.87

74.51

u/l

0.31

549

Congenital malformations of the circulatory system

452

1.46

2.37

1.3

1.2

126.63

81.26

u/l

0.38

410

Superficial injury of forearm

274

1.61

2.37

1.2

76.21

62.12

u/l

0.34

249

Thyroiditis

259

1.63

2.36

1.1

1.2

54.73

57.96

u/l

0.32

240

Hypertrophy of breast

108

804

1.35

2.36

1.1

1.2

52.35

58.00

u/l

1.19

728

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

186

1481

1.25

2.35

1.2

51.16

65.47

u/l

3.72

163

1343

Burns and corrosions

451

1.47

2.35

1.2

64.95

67.95

u/l

0.14

407

Otitis externa, unspecified

362

1.53

2.34

1.2

76.08

66.88

u/l

0.23

334

Use of donepezil

761

0.66

2.33

1.1

1.2

69.50

61.96

u/l

0.24

675

Erythema multiforme

2.20

2.32

1.1

51.53

52.07

u/l

0.03

Premature rupture of membranes

570

0.66

2.30

1.2

52.99

58.47

u/l

0.63

527

Flat foot [pes planus] (acquired)

364

1.52

2.29

1.1

56.30

59.40

u/l

0.20

321

Other hearing loss

158

1217

1.27

2.29

1.2

56.18

62.58

u/l

1.01

142

1071

Hypertrophy of breast in women and men

118

895

1.32

2.28

1.1

1.2

54.18

59.16

u/l

0.76

107

812

Toxic effects of substances chiefly nonmedicinal as to source

349

1.52

2.26

1.1

1.2

61.62

62.51

u/l

0.04

317

Toxic effect of ethanol

113

1.96

2.25

1.1

1.2

75.64

55.92

u/l

0.47

107

Other predominantly sexually transmitted diseases, not elsewhere classified

572

1.40

2.25

1.2

69.61

59.77

u/l

0.64

526

Fistulae involving female genital tract

2.44

2.21

1.1

1.2

51.69

62.21

u/l

0.84

Leiomyoma of uterus

402

1960

1.16

2.20

1.2

59.13

58.11

u/l

0.20

359

1770

Alzheimer’s disease, strict definition

851

0.71

2.19

1.1

1.2

54.38

60.60

u/l

0.61

763

Dementia

169

1452

0.80

2.18

1.1

1.2

66.50

60.73

u/l

0.50

144

1295

Superficial injury of shoulder and upper arm

385

1.49

2.17

1.2

68.69

63.96

u/l

0.18

348

Unspecified mental disorder

214

1756

1.22

2.16

1.1

1.2

56.23

62.46

u/l

1.01

188

1579

False labour

768

0.74

2.16

1.1

1.2

53.15

57.97

u/l

0.87

703

Diseases of inner ear

319

2629

1.18

2.13

1.2

55.70

61.26

u/l

1.45

287

2339

Erectile dysfunction

243

1.61

2.13

1.2

87.14

66.49

u/l

0.43

217

Dementia in Alzheimer disease

557

0.65

2.12

1.0

1.2

59.11

59.78

u/l

0.03

501

Dementia, including avohilmo

184

1557

0.81

2.09

1.1

1.2

64.73

63.52

u/l

0.08

157

1390

Scabies

413

1.46

2.09

1.1

1.2

70.77

69.47

u/l

0.05

377

Abdominal aortic aneurysm (AAA)

289

1.55

2.09

1.2

41.87

64.41

u/l

2.63

254

Mixed conductive and sensorineural hearing loss

480

1.42

2.08

1.2

52.48

64.07

u/l

1.69

428

Type of accident

153

1217

1.26

2.08

1.2

73.67

63.34

u/l

1.14

137

1085

Migraine

263

1790

1.19

2.06

1.2

54.08

64.53

u/l

2.81

239

1605

Injuries to the neck

110

840

1.31

2.06

1.2

55.39

61.66

u/l

0.97

759

Disorders of vestibular function (Vertigo)

276

2296

1.18

2.04

1.2

56.00

61.69

u/l

1.28

248

2041

Ill-defined and unknown causes of mortality

262

1.57

2.03

1.3

1.2

62.86

67.42

u/l

0.11

233

Pollen allergy

594

1.37

2.00

1.2

62.65

73.72

u/l

0.34

543

Other and unspecified rosacea

319

1.51

2.00

1.2

50.93

58.59

u/l

0.77

294

Migraine without aura

748

1.33

2.00

1.1

1.2

60.09

66.26

u/l

0.42

682

Postmenopausal bleeding

197

856

1.23

2.00

1.2

57.71

57.76

u/l

0.01

179

764

Congenital malformations of heart and great arteries

389

1.45

1.98

1.3

1.2

145.48

81.18

u/l

0.47

355

Coxibs

149

620

1.27

1.96

1.1

1.2

63.21

68.03

u/l

0.30

136

571

Spinal instabilities

1.95

1.96

1.0

1.2

55.47

53.77

u/l

0.08

Habitual aborter

2.58

1.94

1.1

1.2

77.60

57.21

u/l

—

Diseases of male genital organs

233

976

1.21

1.94

1.2

68.73

74.14

u/l

0.31

204

876

Adverse effects, not elsewhere classified

753

1.32

1.93

1.2

53.10

66.33

u/l

1.73

689

Presbycusis

519

1.38

1.88

1.1

1.2

48.75

65.33

u/l

3.13

451

Moderate visual impairment, binocular

2.04

1.86

1.4

1.1

80.19

61.58

u/l

0.61

Strabismus

132

1046

1.26

1.85

1.2

119.95

65.34

u/l

0.94

120

943

Menorrhagia

211

970

1.21

1.85

1.2

56.86

58.04

u/l

0.14

197

871

Benign neoplasm of middle ear and respiratory system

245

1.56

1.84

1.2

54.86

60.51

u/l

0.32

220

Other congenital malformations of urinary system

4.24

1.83

1.8

1.0

218.40

51.83

u/l

—

Herpesviral [herpes simplex] infections

128

1015

1.26

1.83

1.2

56.60

60.22

u/l

0.39

115

915

Benign neoplasm of breast

527

1.37

1.83

1.2

53.47

59.32

u/l

0.65

475

Other shoulder lesions

318

1.48

1.83

1.1

1.2

62.52

58.74

u/l

0.16

290

Contusion of toe(s) without damage to nail

2.14

1.82

1.4

1.2

56.07

52.59

u/l

0.17

Excessive, frequent and irregular menstruation

223

1019

1.20

1.82

1.2

56.27

59.15

u/l

0.45

204

915

Other and unspecified disease of Bartholin gland

1.93

1.81

1.1

1.2

61.08

57.81

u/l

0.13

Glaucoma

333

2486

1.15

1.80

1.2

55.74

61.42

u/l

1.40

294

2214

LSIL lesion of the cervix uteri, vagina or vulva

521

1.37

1.78

1.1

1.2

59.34

56.84

u/l

0.18

477

Maternal care related to the fetus and amniotic cavity and possible delivery problems

187

1325

0.83

1.78

1.2

64.72

58.43

u/l

0.47

172

1213

Coxarthrosis, primary

355

2622

1.15

1.78

1.2

59.88

62.17

u/l

0.27

319

2335

Arthropod-borne viral fevers and viral haemorrhagic fevers

677

1.32

1.76

1.2

60.42

69.52

u/l

0.69

609

Other disorders of ear

545

3195

1.12

1.74

1.2

58.16

64.46

u/l

1.41

498

2855

Other predominantly sexually transmitted diseases, not elsewhere classified

670

1.32

1.73

1.2

68.30

61.57

u/l

0.43

616

Other and unspecified tonsillitis

131

880

1.25

1.73

1.2

74.19

70.84

u/l

0.06

117

796

Polyarteritis nodosa

3.90

1.72

1.2

40.60

50.46

u/l

—

Contact with and exposure to communicable diseases

131

1046

1.25

1.72

1.3

1.2

84.81

63.05

u/l

0.50

110

958

Ptosis of eyelid

440

1.39

1.71

1.2

50.83

61.77

u/l

1.39

400

Allergic contact dermatitis due to drugs in contact with skin

2.08

1.71

1.4

1.1

65.21

51.58

u/l

0.30

Unspecified event, undetermined intent

2.02

1.70

1.0

1.2

44.51

49.23

u/l

0.28

Acute alcohol intoxication, ICD10

690

1.31

1.70

1.1

1.2

72.75

63.68

u/l

0.45

619

Pre-eclampsia or eclampsia

121

964

1.26

1.69

1.2

56.02

57.56

u/l

0.16

114

869

Kela-code for severe mental illness

185

1541

1.20

1.69

1.1

1.2

57.23

62.91

u/l

0.76

161

1387

Abnormal spermatozoa

383

1.41

1.67

1.1

1.2

84.57

71.04

u/l

0.35

333

Infections specific to the perinatal period

3.19

1.66

1.3

1.1

65.33

336.16

u/l

—

Use of rivastigmine

549

0.67

1.66

1.0

1.2

62.33

62.96

u/l

0.03

484

Vasomotor and allergic rhinitis

192

1579

1.20

1.65

1.2

58.29

68.81

u/l

0.88

180

1418

Artificial joint operation, meniscal resection

544

3174

1.11

1.65

1.2

56.75

62.88

u/l

1.84

490

2847

Acute epiglottitis

2.46

1.65

1.1

1.2

46.20

48.49

u/l

—

Alcohol abuse, main dg

512

1.35

1.64

1.1

1.2

60.38

63.85

u/l

0.25

456

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.98

1.63

1.2

82.33

120.31

u/l

0.44

Pathological resorption of teeth

113

1.78

1.61

1.3

1.2

54.05

55.43

u/l

0.07

105

Antenatal screening

551

0.75

1.60

1.2

69.54

58.46

u/l

0.33

504

Effects of foreign body entering through natural orifice

110

873

1.26

1.60

1.2

60.34

70.50

u/l

0.79

781

Pre-eclampsia

109

865

1.26

1.59

1.2

55.60

56.86

u/l

0.13

103

778

Disorders of ocular muscles, binocular movement, accommodation and refraction

240

2039

1.17

1.59

1.2

77.84

64.52

u/l

0.57

217

1827

Lichen planus

532

1.34

1.59

1.2

58.51

62.07

u/l

0.24

478

Acetic acid derivatives and related substances

144

608

1.23

1.54

1.1

1.2

58.82

66.97

u/l

0.73

137

559

Other and unspecified nonorganic psychotic disorders

640

1.30

1.53

1.1

1.2

64.82

60.81

u/l

0.21

588

Extrapyramidal and movement disorders

207

1761

1.18

1.53

1.2

58.92

61.80

u/l

0.43

184

1569

Other strabismus

104

823

1.26

1.52

1.2

138.52

65.04

u/l

1.02

746

Routine general health check-up of defined subpopulation

2.17

1.51

1.2

1.1

58.27

64.02

u/l

0.26

Hyperosmolality and hypernatraemia

2.46

1.48

1.6

1.0

61.00

44.81

u/l

—

Other obstetric conditions, not elsewhere classified

121

620

1.24

1.48

1.2

62.16

58.70

u/l

0.14

110

573

Granuloma annulare

2.24

1.47

1.1

58.40

58.37

u/l

—

Atrophic disorders of skin

627

1.30

1.47

1.1

1.2

57.76

60.71

u/l

0.28

555

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

326

1.42

1.46

1.3

1.2

52.32

57.63

u/l

0.41

298

LSIL lesion of the cervix uteri

368

1.39

1.46

1.1

1.2

63.83

58.87

u/l

0.28

341

Other abnormal uterine and vaginal bleeding

143

843

1.22

1.46

1.2

58.19

57.77

u/l

0.04

132

748

Coxarthrosis, primary, with hip surgery

273

2228

1.15

1.46

1.2

58.12

60.62

u/l

0.31

246

1983

Hallux valgus (acquired)

186

1129

1.19

1.46

1.2

54.56

65.26

u/l

2.46

175

1009

Migraine with aura and triptan purchases

549

1.31

1.46

1.3

1.2

49.14

60.18

u/l

2.20

506

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

116

592

1.25

1.45

1.2

63.45

59.05

u/l

0.18

105

548

Any dementia

154

1280

0.83

1.43

1.1

1.2

63.70

61.22

u/l

0.16

132

1137

Temporomandibular joint disorders, including avohilmo

225

1912

1.16

1.42

1.2

61.31

60.31

u/l

0.07

197

1730

Alopecia areata

1.86

1.40

1.1

1.2

47.47

86.47

u/l

0.69

Dissociative [conversion] disorders

1.86

1.40

1.1

43.22

51.24

u/l

0.77

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

212

0.52

1.40

1.4

1.2

59.64

58.13

u/l

0.05

197

Irregular menses

261

1796

1.15

1.39

1.2

56.73

59.24

u/l

0.41

244

1622

Other symptoms and signs involving the urinary system

338

1.39

1.3

1.2

60.33

67.72

u/l

0.53

303

Corneal degeneration

2.10

1.39

1.1

1.2

56.78

51.80

u/l

0.23

Pregnancy hypertension

221

1707

1.16

1.39

1.2

58.01

58.63

u/l

0.07

207

1550

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

190

1.53

1.37

1.1

1.2

59.92

57.39

u/l

0.09

176

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

232

1.47

1.34

1.1

1.2

58.33

55.99

u/l

0.12

215

Haemangioma and lymphangioma, any site

325

1.39

1.31

1.2

57.00

61.05

u/l

0.25

300

Alzheimer’s disease (Late onset), excluding more controls

390

0.72

1.31

1.1

1.2

53.84

65.79

u/l

0.85

347

Combinations of oral blood glucose lowering drugs

143

1198

1.20

1.31

1.2

60.85

64.13

u/l

0.19

125

1055

Injury of muscle and tendon at hip and thigh level

317

1.39

1.30

1.1

1.2

54.16

59.10

u/l

0.41

292

Demyelinating diseases of the central nervous system

275

1.42

1.30

1.2

46.62

58.66

u/l

1.18

253

Benign neoplasm of mouth and pharynx

386

1.35

1.29

1.2

50.64

61.07

u/l

1.00

351

Rosacea

438

1.33

1.29

1.2

55.83

56.92

u/l

0.07

400

Melanoma in situ of trunk

2.06

1.27

1.0

1.2

62.33

43.51

u/l

—

Malignant neoplasm of tongue

2.06

1.27

1.4

1.2

69.33

44.89

u/l

—

Haemorrhage in early pregnancy

102

1215

0.82

1.27

1.2

57.52

57.94

u/l

0.03

1102

Other fall from one level to another

777

1.24

1.3

1.2

59.64

71.66

u/l

1.24

699

Postmenopausal atrophic vaginitis

182

858

1.17

1.24

1.2

60.00

57.67

u/l

0.29

166

765

Pre-eclampsia or poor fetal growth

149

1256

1.18

1.23

1.3

1.2

55.64

59.00

u/l

0.46

139

1146

Muscle strain

1.77

1.23

1.3

1.2

73.87

55.86

u/l

0.44

Migraine, single triptan purchase ok & required. ICD-code if available is included

423

2592

1.11

1.22

1.2

56.44

63.31

u/l

2.41

387

2335

Triptan medication for migraine, single purchase ok

423

2592

1.11

1.22

1.2

56.44

63.31

u/l

2.41

387

2335

Injury of urinary and pelvic organs

1.98

1.22

1.2

53.09

48.53

u/l

0.28

Nontraumatic intracranial haemmorrhage

798

1.23

1.21

1.3

1.2

57.62

64.62

u/l

0.66

720

Medical abortion

374

1823

1.11

1.20

1.2

55.33

59.54

u/l

1.08

338

1634

Unspecified chronic bronchitis

101

1.69

1.20

1.4

1.2

45.83

64.09

u/l

1.13

Glaucoma-related operations

197

1.48

1.19

1.1

1.2

48.17

61.42

u/l

0.85

177

Other condition

508

1.28

1.15

1.2

67.90

63.21

u/l

0.28

458

Other diseases of spinal cord

103

1.66

1.13

1.3

1.2

56.52

50.52

u/l

0.28

Salpingitis and oophoritis

108

897

1.21

1.13

1.3

1.2

62.38

57.95

u/l

0.38

810

Scleritis and episcleritis

208

1.45

1.13

1.1

1.2

44.90

62.56

u/l

1.65

189

Pain and other conditions associated with female genital organs and menstrual cycle

749

1.22

1.11

1.1

1.2

52.27

58.97

u/l

1.19

681

Focal epilepsy

816

1.21

1.11

1.2

66.99

70.28

u/l

0.13

731

Complications of labour and delivery

299

1857

0.89

1.10

1.2

57.29

58.86

u/l

0.27

268

1674

Benign lipomatous neoplasm

116

1379

0.84

1.10

1.1

1.2

62.59

62.53

u/l

0.00

103

1220

Schizophrenia or delusion, excluding more controls

135

1136

1.18

1.09

1.1

1.2

63.58

61.49

u/l

0.14

117

1030

Mouth breathing

201

1760

1.14

1.08

1.2

56.69

69.45

u/l

2.63

183

1568

Benign neoplasm: Skin, unspecified

128

1.57

1.08

1.4

1.2

69.90

52.83

u/l

0.65

120

Haemangioma, any site

296

1.36

1.06

1.2

58.09

57.72

u/l

0.02

275

Pediculosis, acariasis and other infestations

524

1.26

1.05

1.1

1.2

70.05

65.65

u/l

0.21

478

Foreign body entering into or through eye or natural orifice

237

1.40

1.04

1.7

1.2

63.79

62.68

u/l

0.04

218

Redundant prepuce, phimosis and paraphimosis

644

1.23

1.04

1.4

1.2

60.22

77.30

u/l

1.57

574

Bell's palsy

419

1.29

1.04

1.2

43.52

61.13

u/l

3.53

370

Dislocation, sprain and strain of joints and ligaments at neck level

481

1.27

1.03

1.1

1.2

53.65

61.49

u/l

1.06

444

Other and unspecified epidermal thickening

1.74

1.03

1.5

1.1

52.23

51.37

u/l

0.03

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

1.93

1.02

1.2

105.00

45.80

u/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

247

1916

1.12

1.01

1.2

59.33

58.64

u/l

0.09

233

1734

Other and unspecified effects of external causes

127

1083

1.17

1.01

1.2

57.78

66.87

u/l

1.02

113

976

Nontoxic goitre/thyroid nodule

168

1465

1.15

1.00

1.1

1.2

59.84

59.04

u/l

0.07

152

1308

Use of antiglaucoma preparations and miotics

282

1.35

1.00

1.1

1.2

56.97

61.87

u/l

0.16

250

Anorexia (incl.atypical)

148

1.49

0.97

1.2

65.64

66.80

u/l

0.02

141

Carcinoma in situ of other and unspecified digestive organs

100

1.61

0.97

1.1

1.2

88.19

51.94

u/l

0.40

Foreign body in alimentary tract

165

1.46

0.96

1.3

1.2

52.84

79.40

u/l

0.92

156

All dysplastic lesions of the cervix uteri, vagina or vulva

136

1155

1.16

0.96

1.2

56.51

58.47

u/l

0.21

124

1053

Tonsillectomy and adenotomy

212

1658

0.89

0.94

1.2

64.06

68.47

u/l

0.29

191

1516

Anankastic personality disorder

117

1.54

0.93

1.1

1.2

51.16

52.39

u/l

0.06

111

Hydrocele

382

1.29

0.93

1.1

1.2

77.60

72.37

u/l

0.11

337

Achilles tendinitis

409

1.27

0.93

1.2

48.61

64.76

u/l

2.11

364

Lesion of ulnar nerve

527

1.24

0.90

1.2

58.82

59.80

u/l

0.06

471

Other specific arthropathies, wide

1.76

0.90

1.4

1.1

52.64

52.72

u/l

0.00

Benign neoplasm of meninges

411

1.27

0.90

1.3

1.2

57.56

57.62

u/l

0.00

377

Acute alcohol intoxication

110

939

1.17

0.89

1.1

1.2

67.94

65.53

u/l

0.11

842

Any dementia, excluding more controls

144

1136

0.87

0.89

1.2

63.74

61.09

u/l

0.17

123

1014

Lichen planus, including avohilmo

839

1.18

0.88

1.2

61.55

60.81

u/l

0.05

746

Covid-19 suspected case

802

1.19

0.88

1.3

1.2

54.43

61.70

u/l

0.87

722

Maternal care for other known or suspected fetal problems

512

0.82

0.87

1.2

50.41

58.49

u/l

1.09

474

Single delivery by caesarean section

476

0.82

0.86

1.2

1.3

49.94

62.07

u/l

1.81

442

Other obstetric trauma

153

1.44

0.85

1.2

54.50

65.28

u/l

0.58

144

Malignant neoplasm of other and unspecified parts of biliary tract

1.95

0.84

1.2

1.3

118.00

44.64

u/l

—

Migraine with aura

112

964

1.16

0.84

1.3

1.2

52.28

63.31

u/l

1.76

103

868

Other spirochaetal diseases

160

1413

1.13

0.84

1.2

53.12

62.77

u/l

2.71

148

1256

Early syphilis

1.88

0.82

1.5

1.2

35.17

54.06

u/l

—

Secondary polycythaemia

1.65

0.82

1.1

1.2

54.41

48.90

u/l

0.36

Other inflammation of vagina/vulva

1.58

0.81

1.1

49.21

60.03

u/l

0.76

Diseases of appendix

389

3246

1.08

0.80

1.2

55.26

63.17

u/l

2.23

354

2925

Abrasion of teeth

181

1619

1.12

0.78

1.2

65.64

60.47

u/l

0.51

159

1459

Other disorders of the genitourinary system

584

1.20

0.77

1.3

1.2

53.64

58.58

u/l

0.48

526

Noise effects on inner ear

100

0.50

0.77

1.0

1.2

43.06

59.57

u/l

—

Paraplegia, diplegia of upper limbs

1.61

0.75

1.3

1.2

55.83

55.00

u/l

0.02

Keratoconus

1.61

0.75

1.1

1.2

41.72

51.73

u/l

0.41

Other intracranial haemorrhages

1.57

0.75

1.6

1.1

44.31

50.90

u/l

0.39

Retinal breaks without detachment

669

1.18

0.75

1.2

51.45

64.70

u/l

1.90

599

Abnormal findings in secretions and smears from cervix uteri vagina vulva

261

1802

1.10

0.74

1.2

61.71

58.03

u/l

0.34

233

1645

Lyme disease

158

1409

1.12

0.74

1.2

53.62

62.76

u/l

2.47

146

1253

Abnormal involuntary movements

496

1.21

0.73

1.2

54.41

62.48

u/l

0.66

446

Primary coxarthrosis, bilateral

149

1325

1.13

0.73

1.2

62.04

62.12

u/l

0.00

133

1167

Spirochaetal infections, other/unspecified

158

1410

1.12

0.73

1.2

53.62

62.81

u/l

2.50

146

1253

Suggestive for eosinophilic asthma

325

1.26

0.73

1.1

61.42

64.01

u/l

0.15

293

Other abnormal findings in urine

1.80

0.72

1.1

72.90

46.15

u/l

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.76

0.71

1.3

1.2

59.71

50.14

u/l

—

Other disorders of pigmentation

134

1.42

0.71

1.3

1.2

71.16

55.76

u/l

0.43

123

Burn and corrosion of wrist and hand

109

1.47

0.71

1.1

1.2

55.05

57.75

u/l

0.10

103

Other benign neoplasms of skin

193

1746

1.11

0.70

1.3

1.2

60.96

61.74

u/l

0.07

178

1555

Other spirochaetal diseases

160

1433

1.12

0.70

1.2

53.12

62.86

u/l

2.78

148

1275

Sequelae of tuberculosis

1.71

0.70

1.0

1.1

58.57

48.76

u/l

—

Early syphilis

1.86

0.68

1.4

1.3

32.40

46.48

u/l

—

Peritonsillar abscess

732

1.16

0.67

1.2

72.38

59.22

u/l

0.58

651

Allergic rhinitis

137

1207

1.12

0.66

1.2

62.01

68.92

u/l

0.33

128

1097

Injury of muscle and tendon at wrist and hand level

475

1.20

0.66

1.3

1.2

68.56

63.64

u/l

0.23

431

Occlusion and stenosis of arteries, not leading to stroke

1.79

0.66

1.2

1.1

48.80

55.87

u/l

—

Supervision of normal pregnancy

532

0.86

0.65

1.1

1.2

69.20

58.59

u/l

0.34

487

Other disorders of penis

295

1.26

0.64

1.2

69.66

77.79

u/l

0.14

261

Parkinson's disease, including avohilmo

602

0.83

0.64

1.3

1.2

59.30

66.45

u/l

0.65

537

Appendicitis, broad definition

382

3233

1.07

0.64

1.2

55.32

63.22

u/l

2.17

347

2912

Other acute disseminated demyelination

1.73

0.64

1.4

1.2

48.60

60.61

u/l

—

Varicose veins

353

2486

1.07

0.64

1.2

64.40

60.85

u/l

0.14

313

2229

Perforation of tympanic membrane

332

1.24

0.63

1.2

59.06

67.47

u/l

0.54

302

Diabetes mellitus in pregnancy

135

771

1.12

0.62

1.3

1.2

51.45

58.21

u/l

1.20

125

708

Other female pelvic inflammatory diseases

720

1.15

0.62

1.3

1.2

65.41

58.03

u/l

0.55

648

Foreign body on external eye

443

1.20

0.61

1.2

70.71

61.40

u/l

0.38

397

Other specified disorders of external ear

113

1.42

0.61

1.2

105.02

60.98

u/l

0.56

107

Migraine without aura and triptan purchases

600

1.17

0.61

1.1

1.2

55.34

58.32

u/l

0.33

549

Obstructed labour due to maternal pelvic abnormality

781

0.86

0.60

1.3

1.2

58.96

59.41

u/l

0.03

706

Iridocyclitis in diseases classified elsewhere

1.57

0.60

1.3

1.1

81.13

48.66

u/l

—

Gestational diabetes (for exclusion)

154

966

1.11

0.60

1.2

52.75

58.27

u/l

1.07

143

887

Endometriosis of ovary

752

1.14

0.58

1.2

57.51

58.06

u/l

0.04

676

Disorders of refraction and accommodation

119

1059

1.12

0.58

1.2

88.65

64.03

u/l

0.38

108

954

Cerebral aneurysm, nonruptured

318

1.23

0.58

1.2

48.58

56.68

u/l

1.01

296

Malignant neoplasm of other and unspecified parts of tongue

1.72

0.58

1.7

1.2

84.17

45.22

u/l

—

Acute appendicitis, no complications

275

2546

1.08

0.57

1.2

57.18

63.80

u/l

1.13

246

2286

Parkinson's disease, strict definition

529

0.83

0.57

1.3

1.2

59.13

65.81

u/l

0.56

472

Other disorders of eyelid

244

2153

1.08

0.56

1.2

61.66

61.08

u/l

0.06

217

1918

Malignant neoplasm of cervix uteri, including Hilmo

1.54

0.55

1.0

1.2

49.00

51.94

u/l

—

Acute appendicitis

355

3118

1.06

0.55

1.2

55.43

63.13

u/l

1.98

320

2809

Lichen ruber planus, wide definition including periferal and oral lichen planus

115

1030

1.12

0.55

1.2

57.83

61.65

u/l

0.34

101

916

Dentofacial anomalies [including malocclusion]

359

2710

1.06

0.55

1.2

68.28

64.00

u/l

0.40

325

2451

Fourth [trochlear] nerve palsy

1.47

0.54

1.3

1.2

48.42

52.70

u/l

0.18

Other autoimmune haemolytic anaemias

1.59

0.54

1.3

1.2

44.00

44.52

u/l

—

Glaucoma suspect

193

1777

1.09

0.54

1.2

57.55

62.65

u/l

0.71

168

1567

Other melanin hyperpigmentation

1.46

0.53

1.3

1.2

43.00

51.34

u/l

—

Outcome of delivery

391

0.85

0.52

1.1

1.2

51.61

57.01

u/l

0.55

359

Nontoxic multinodular goitre

101

903

1.12

0.51

1.2

63.71

58.84

u/l

0.33

808

Excessive earwax

282

2578

1.07

0.50

1.2

58.18

66.17

u/l

1.38

253

2301

Other abnormal products of conception

125

913

0.91

0.49

1.2

60.55

60.52

u/l

0.00

115

842

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

541

0.85

0.49

1.1

59.28

61.89

u/l

0.15

492

Anti-inflammatory and antirheumatic products, non-steroids

140

639

1.10

0.49

1.1

1.2

65.52

72.26

u/l

0.39

126

589

Parkinson's disease

573

0.85

0.49

1.3

1.2

59.71

66.03

u/l

0.54

512

Vascular dementia (mixed)

1.56

0.49

1.1

76.00

57.24

u/l

—

Periapical abscess

226

2106

1.07

0.48

1.3

1.2

75.66

62.33

u/l

0.73

200

1878

Carcinoma in situ of breast, other/unspecified

1.50

0.47

1.3

1.1

53.57

54.16

u/l

—

Abnormal findings on diagnostic imaging of central nervous system

137

1.32

0.47

1.3

1.2

47.40

55.62

u/l

0.64

127

Secondary parkinsonism

0.61

0.46

1.4

1.2

87.80

50.36

u/l

—

Dysplasia of cervi uteri

118

776

1.10

0.45

1.2

58.80

57.97

u/l

0.07

108

706

Additional codes for the location of defect, injury or illness

183

1.26

0.45

1.2

63.49

71.98

u/l

0.22

169

Inguinal hernia

232

1657

0.94

0.44

1.2

72.21

64.52

u/l

0.45

201

1476

Juvenile osteochondrosis

1.40

0.44

1.4

1.2

80.67

57.54

u/l

0.42

Episcleritis

184

1.25

0.43

1.2

40.35

58.49

u/l

2.59

168

Disorder of external ear, unspecified

104

1.35

0.43

1.2

58.96

52.95

u/l

0.16

Other peripheral vertigo

359

1.17

0.42

1.2

55.14

58.78

u/l

0.29

324

Rubella [German measles]

0.65

0.42

1.2

57.33

51.94

u/l

—

Postpartum haemorrhage due to retained placenta

391

0.84

0.41

1.2

48.44

58.41

u/l

0.94

361

Impacted maxillary canine

0.00

0.40

0.0

1.0

—

113.11

—

Other benign neoplasms of connective and other soft tissue

352

1.17

0.40

1.3

1.2

64.87

63.93

u/l

0.03

325

Specific development disorders of speech and language

136

1.28

0.39

1.2

83.78

102.64

u/l

0.53

124

Alzheimer disease, excluding more controls

481

0.89

0.38

1.1

1.2

64.27

72.76

u/l

0.25

424

Desensitization to allergens

133

1.28

0.38

1.2

109.95

59.39

u/l

0.39

125

Benign neoplasm of major salivary glands

345

1.16

0.37

1.3

1.2

65.72

64.54

u/l

0.04

312

All dysplastic lesions of the cervix uteri

108

983

1.09

0.37

1.2

58.50

58.78

u/l

0.02

905

Bicipital tendinitis

147

0.75

0.37

1.0

1.2

49.91

57.59

u/l

0.52

138

Impacted maxillary molar

114

0.70

0.37

1.1

1.2

97.25

63.82

u/l

—

105

Use of ropinirole

115

0.69

0.37

1.4

1.2

47.13

50.60

u/l

—

106

Cyst of Bartholin Gland

116

1.30

0.37

1.1

63.35

60.25

u/l

—

108

Placenta praevia

115

0.69

0.37

1.4

1.2

47.91

56.86

u/l

—

109

Uterine polyps

487

1.13

0.36

1.2

61.00

57.70

u/l

0.24

440

Secondary parkinsonism, excluding more controls

0.65

0.35

1.4

1.1

87.80

48.83

u/l

—

Benign neoplasm: Cerebral meninges

376

1.15

0.35

1.2

59.52

57.84

u/l

0.10

346

HSIL lesion of the cervix uteri, vagina or vulva

747

1.10

0.34

1.2

56.02

55.72

u/l

0.02

683

Malignant neoplasm of ovary

166

0.78

0.33

1.2

55.54

61.33

u/l

0.32

151

Secondary parkinsonism+Parkinsonism in other disease

0.69

0.33

1.5

1.2

77.67

51.87

u/l

—

Distal bite

0.68

0.33

1.3

1.1

54.38

131.33

u/l

—

Lateral epicondylitis

559

1.11

0.32

1.2

54.10

56.92

u/l

0.25

507

Schizophrenia, schizotypal and delusional disorders

136

1271

1.07

0.32

1.1

1.2

64.95

61.26

u/l

0.27

118

1143

Primary open-angle glaucoma, strict

132

1230

1.07

0.32

1.2

56.03

62.43

u/l

0.81

115

1085

Medical treatment for female infertility

699

1.10

0.31

1.3

1.2

62.65

56.65

u/l

0.74

643

Tinnitus

115

1070

1.08

0.31

1.2

59.78

62.62

u/l

0.15

102

942

Persons encountering health services in circumstances related to reproduction

290

1868

1.05

0.30

1.2

77.38

66.14

u/l

0.56

263

1691

Deviated nasal septum

146

1371

1.06

0.30

1.3

1.2

59.81

65.26

u/l

0.64

133

1221

Exposure to other and unspecified animate mechanical forces

1.31

0.30

1.1

1.2

62.48

61.34

u/l

0.04

Labour and delivery complicated by fetal stress [distress]

489

0.91

0.30

1.3

1.2

57.12

61.51

u/l

0.38

448

Conductive and sensorineural hearing loss

437

2846

1.04

0.29

1.2

58.49

62.45

u/l

0.62

404

2537

Benign neoplasm: Parotid gland

269

1.15

0.29

1.3

1.2

70.67

65.86

u/l

0.16

247

Serous carcinoma of ovary, including Hilmo

109

0.73

0.29

1.4

1.1

60.13

56.77

u/l

—

Intussusception

1.23

0.29

1.0

1.1

49.86

57.12

u/l

—

Prolapse and hernia of ovary and fallopian tube

139

0.78

0.28

1.3

1.2

59.55

61.43

u/l

0.11

119

Other degenerative diseases of the nervous system

128

896

1.07

0.28

1.2

62.12

67.16

u/l

0.28

104

803

Schizophrenia or delusion

135

1270

1.06

0.28

1.1

1.2

63.58

61.51

u/l

0.14

117

1141

Female genital prolapse

170

909

1.06

0.27

1.1

1.2

60.62

57.44

u/l

0.37

148

812

Adenocarcinoma of pancreas

1.25

0.27

1.3

1.2

62.38

50.03

u/l

—

Myopia

404

1.11

0.26

1.3

1.2

145.10

65.22

u/l

0.46

371

Benign mammary dysplasia

664

1.09

0.26

1.2

60.48

60.71

u/l

0.01

592

Lichen sclerosus et atrophicus

436

0.89

0.26

1.1

1.2

59.79

56.61

u/l

0.22

392

Benign neoplasm: salivary glands, exclude unknown (D119)

301

1.13

0.25

1.3

1.2

69.19

64.54

u/l

0.16

276

Benign neoplasm: Skin of eyelid, including canthus

654

0.92

0.25

1.2

54.87

62.30

u/l

0.93

590

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.27

0.24

1.4

1.2

76.00

59.26

u/l

0.31

Viral infections of the central nervous system

237

1.14

0.23

1.2

63.00

58.56

u/l

0.20

221

Oral lichen planus, including avohilmo , including avohilmo

266

1.13

0.22

1.2

41.60

59.72

u/l

2.63

246

Spontaneous abortion

220

1542

0.96

0.21

1.2

55.20

59.44

u/l

0.79

209

1393

Retained placenta and membranes, without haemorrhage

555

0.92

0.21

1.2

52.73

58.78

u/l

0.73

507

Organic, including symptomatic, mental disorders

258

1771

1.04

0.21

1.2

63.39

62.84

u/l

0.04

227

1573

Presbyopia

229

1.14

0.21

1.2

55.77

64.26

u/l

0.63

209

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.21

0.0

1.0

—

369.20

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.21

0.0

1.0

—

404.36

—

Other sexually transmitted chlamydial diseases

135

1.19

0.21

1.1

1.2

61.38

57.04

u/l

0.10

125

Vascular dementia (subcortical)

1.23

0.21

1.0

1.2

60.50

55.55

u/l

0.21

Major anomalies of jaw size

1.24

0.21

1.1

1.2

50.82

56.79

u/l

0.40

Slow fetal growth and fetal malnutrition

0.00

0.21

0.0

1.0

—

398.69

—

Other noninflammatory disorders of uterus, except cervix

129

826

1.05

0.20

1.2

54.70

57.96

u/l

0.51

116

735

Glucosamine medication

249

2057

0.97

0.20

1.2

58.76

61.11

u/l

0.28

218

1826

Anomalies of dental arch relationship, including avohilmo

641

1.07

0.20

1.2

84.23

69.68

u/l

0.58

584

Traumatic amputation of wrist and hand

123

0.81

0.20

1.0

1.2

63.60

62.00

u/l

—

115

Male infertility

114

0.79

0.20

1.3

1.2

44.67

63.68

u/l

—

100

HSIL lesion of the cervix uteri

645

1.07

0.19

1.2

57.61

56.47

u/l

0.08

589

Use of levodopa decarboxylase inhibitor

510

0.92

0.19

1.3

1.2

73.20

64.09

u/l

0.40

455

Primary open-angle glaucoma

158

1466

1.04

0.18

1.2

53.67

61.99

u/l

1.50

138

1300

Pedal cyclist injured in transport accident

868

0.94

0.18

1.4

1.2

64.86

63.85

u/l

0.04

777

Other acquired deformities of musculoskeletal system and connective tissue

147

1.16

0.18

1.2

53.34

57.01

u/l

0.13

139

Dislocation, sprain and strain of joints and ligaments of knee

267

2533

0.97

0.17

1.2

54.53

64.48

u/l

2.24

249

2278

Other bullous disorders

1.21

0.17

1.1

1.2

63.55

53.23

u/l

0.23

Viral meningitis

110

1.18

0.17

1.2

74.00

59.44

u/l

0.40

103

Malignant neoplasm of ovary, including Hilmo

236

0.89

0.16

1.2

1.1

54.33

58.97

u/l

0.37

210

Injury of muscle and tendon at lower leg level

514

1.07

0.16

1.5

1.2

85.56

62.39

u/l

0.70

462

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

112

1171

0.96

0.16

1.3

1.2

53.58

64.39

u/l

1.97

1039

Carcinoma in situ of colon

1.16

0.16

1.0

1.2

49.25

50.23

u/l

—

Mental and behavioural disorders due to cannabinoids

1.13

0.16

1.0

1.2

85.00

61.02

u/l

—

Blepharochalasis

154

1485

1.04

0.16

1.2

60.11

61.49

u/l

0.11

138

1326

Other maternal disorders predominantly related to pregnancy

286

1841

0.97

0.16

1.2

56.80

58.70

u/l

0.34

262

1666

Non-invasive ventilation

660

1.06

0.16

1.2

55.20

66.60

u/l

1.23

596

Epiphora

0.78

0.15

1.2

57.67

57.97

u/l

—

Autonomic disorders

1.16

0.15

1.0

1.2

74.33

49.95

u/l

—

Tooth agenesis EXCLUDE clefts and syndromes

1.15

0.15

1.1

1.2

419.11

89.44

u/l

—

Long labour

825

0.95

0.15

1.3

1.2

53.13

61.16

u/l

1.28

752

Injury of muscle and tendon at shoulder and upper arm level

151

1563

0.97

0.15

1.1

1.2

55.66

62.70

u/l

0.77

139

1379

Other vitreous opacities

129

0.85

0.14

1.1

1.2

45.36

54.30

u/l

0.49

120

Testicular hypofunction

0.80

0.14

1.4

1.2

49.43

65.14

u/l

—

Pedal cyclist injured in noncollision transport accidents

398

0.93

0.14

1.1

1.2

48.41

61.72

u/l

1.89

364

Maternal care for known or suspected abnormality of pelvic organs

689

0.96

0.13

1.3

1.2

52.75

58.79

u/l

0.91

637

Ectopic pregnancy

838

0.95

0.13

1.1

1.2

57.65

59.56

u/l

0.20

758

Failed induction of labour

132

1.14

0.13

1.1

1.2

57.33

65.34

u/l

0.31

121

Nasal polyp

764

0.96

0.12

1.2

57.59

65.89

u/l

0.92

678

Gestational [pregnancy-induced] hypertension

105

1011

1.04

0.12

1.1

1.2

58.61

57.78

u/l

0.07

912

Pterygium

1.16

0.11

1.1

1.2

71.18

51.73

u/l

0.27

Pregnancy with abortive outcome

358

1834

1.02

0.11

1.2

54.63

59.51

u/l

1.30

323

1645

Complications predominantly related to the puerperium

111

1147

0.97

0.11

1.3

1.2

51.74

57.67

u/l

1.04

102

1045

Acute appendicitis, with complications

831

0.96

0.10

1.2

49.61

63.27

u/l

2.98

742

Disorders of speech understanding and production

1.15

0.10

1.2

103.36

91.32

u/l

0.25

Adhesive middle ear disease

1.14

0.10

1.4

1.1

69.80

58.52

u/l

—

Other and unspecified nerve root and plexus disorders, also in other diseases

809

0.96

0.10

1.2

52.16

59.77

u/l

0.96

718

Triptan medication for migraine, min. 3 purchases

265

2059

0.98

0.10

1.2

52.88

58.84

u/l

2.15

244

1869

Impingement syndrome of shoulder

108

1048

1.03

0.09

1.1

1.2

63.42

62.11

u/l

0.06

101

943

Cervicobrachial syndrome

100

969

1.03

0.09

1.1

1.2

51.09

62.05

u/l

2.48

866

Endometriosis

173

991

1.02

0.09

1.2

53.14

58.52

u/l

1.01

160

892

Postpartum haemorrhage due to anatomy

233

1.07

0.09

1.2

62.24

60.69

u/l

0.06

213

Benign neoplasm of other and unspecified sites

113

0.88

0.08

1.4

1.2

54.23

50.30

u/l

—

107

Torsion of ovary, ovarian pedicle and fallopian tube

1.09

0.08

1.0

1.1

51.00

56.22

u/l

—

Chronic diseases of tonsils and adenoids

390

2495

0.99

0.08

1.2

62.59

67.78

u/l

0.46

357

2240

Supervision of high-risk pregnancy

527

0.97

0.08

1.1

1.2

67.53

58.42

u/l

0.30

483

Exposure to other specified electric current

0.86

0.07

1.5

1.2

65.83

92.44

u/l

—

Puerperal sepsis

642

0.97

0.07

1.2

50.65

59.49

u/l

1.03

581

Alzheimer’s disease (Early onset)

143

0.91

0.07

1.1

1.2

56.92

50.04

u/l

0.36

127

Ulcer of vagina/vulva

1.04

0.07

1.5

1.2

40.75

60.65

u/l

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.87

0.07

1.0

1.2

60.86

56.01

u/l

—

Endometriosis ASRM stages 3,4

104

1015

1.02

0.07

1.2

55.11

57.60

u/l

0.24

912

Cervical disc disorders

168

1650

1.02

0.07

1.2

51.71

62.66

u/l

2.61

156

1464

Manic episode

1.06

0.07

1.8

1.2

59.11

48.85

u/l

—

Effects of other external causes

1.03

0.07

1.1

1.2

38.37

89.30

u/l

—

Burn and corrosion of trunk

0.88

0.06

1.1

1.2

53.75

56.54

u/l

—

Congenital malformations of eye, ear, face and neck

172

0.93

0.06

1.3

1.2

264.56

80.48

u/l

0.42

159

Parkinson's disease, strict definition, excluding more controls

434

0.96

0.05

1.3

1.2

59.13

67.49

u/l

0.67

384

Later onset COPD

120

939

1.02

0.05

1.2

53.98

65.07

u/l

1.42

107

834

Aneurysms, operations, SAH

687

0.98

0.05

1.2

47.73

60.23

u/l

2.77

612

Propionic acid derivatives

125

639

0.98

0.04

1.1

1.2

65.60

72.26

u/l

0.36

114

589

Chronic suppurative otitis media

199

1.06

0.04

1.3

1.2

62.57

81.50

u/l

0.58

184

Glaucoma, exfoliation

402

0.97

0.04

1.2

39.97

64.29

u/l

6.13

359

Examination and encounter for administrative purposes

129

0.93

0.03

1.1

62.08

63.84

u/l

0.05

107

Other facial nerve disorders

1.09

0.03

1.0

1.2

49.20

52.13

u/l

—

Crowding of teeth, including avohilmo

175

1.04

0.02

1.2

104.09

101.25

u/l

0.04

162

Obstructed labour due to malposition and malpresentation of fetus

839

0.99

0.02

1.2

54.37

60.41

u/l

0.80

768

Alzheimer’s disease (Early onset), excluding more controls

116

1.06

0.01

1.1

56.92

57.00

u/l

0.00

103

Schizophrenia

568

0.99

0.01

1.0

1.2

51.58

59.78

u/l

0.89

515

Contraceptive management

193

1360

0.99

0.01

1.3

1.2

61.01

58.82

u/l

0.23

178

1232

Noninflammatory disorders of female genital tract

204

1029

0.99

0.01

1.1

1.2

67.22

60.14

u/l

0.54

188

925

Sensorineural hearing loss

401

2729

1.00

0.01

1.3

1.2

58.31

62.83

u/l

0.68

370

2424

Parkinson's disease, excluding more controls

462

1.00

0.00

1.3

1.2

59.71

66.89

u/l

0.57

409

Open bite

134

0.97

0.00

1.2

385.08

76.14

u/l

0.62

125

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

292

0.99

0.00

1.2

75.04

60.35

u/l

0.61

270

Occupational exposure to risk-factors

101

0.99

0.00

1.2

41.60

53.50

u/l

—

Benign neoplasm of ovary

862

1.00

0.00

1.2

56.76

58.93

u/l

0.17

765

Benign neoplasm: Skin of ear and external auricular canal

119

1.01

0.00

1.3

1.2

69.00

54.87

u/l

0.59

110

Normotensive glaucoma

341

1.00

0.00

1.1

1.2

64.81

61.14

u/l

0.16

307

Other menopausal disorders

152

858

1.00

0.00

1.2

63.75

57.58

u/l

0.34

136

767

Female infertility

136

829

1.00

0.00

1.2

55.05

57.76

u/l

0.28

124

754

Female infertility, cervical, vaginal, other or unspecified origin

125

812

1.00

0.00

1.2

56.63

57.87

u/l

0.10

116

743

Other disorders of prostate

1.05

0.00

1.4

1.1

51.90

72.52

u/l

—

Other and unspecified syphilis

0.00

0.0

1.3

—

53.83

—

Testicular dysfunction

0.94

0.00

1.3

1.2

50.89

67.62

u/l

—

Cicatricial pemphigoid

0.00

0.0

1.3

—

46.17

—

Acne keloid

0.00

0.0

1.0

—

60.22

—

Hypospadias

0.00

-0.00

0.0

1.3

—

98.88

—

Female infertility, uterine origin

0.00

-0.00

0.0

1.2

—

47.22

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.3

—

57.17

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.0

—

360.78

—

Chondromalacia

100

1.00

-0.00

1.0

1.2

49.30

50.41

u/l

—

Constitutional tall stature

0.00

-0.00

0.0

1.0

—

154.67

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.0

—

45.60

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

-0.00

0.0

1.0

—

43.60

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.0

—

76.25

—

Congenital malformations of larynx

0.00

-0.00

0.0

1.0

—

209.83

—

Preterm labour and delivery

124

1240

1.00

-0.00

1.3

1.2

59.99

58.53

u/l

0.15

115

1121

0.00

-0.00

0.0

1.0

—

566.50

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.3

—

59.13

—

Balanced rearrangements and structural markers, not elsewhere classified

0.00

-0.00

0.0

1.4

—

81.00

—

Pedestrian injured in collision with car, pick-up truck or van

0.99

-0.00

1.1

1.2

69.86

51.83

u/l

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.0

—

664.50

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS